{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:52:47Z","timestamp":1794963167854,"version":"4.9.1"},"reference-count":539,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Platelets are essential anucleate blood cells that play pivotal roles in hemostasis, tissue repair, and immune modulation. Originating from megakaryocytes in the bone marrow, platelets are small in size but possess a highly specialized structure that enables them to execute a wide range of physiological functions. The platelet cytoplasm is enriched with functional proteins, organelles, and granules that facilitate their activation and participation in tissue repair processes. Platelet membranes are densely populated with a variety of receptors, which, upon activation, initiate complex intracellular signaling cascades. These signaling pathways govern platelet activation, aggregation, and the release of bioactive molecules, including growth factors, cytokines, and chemokines. Through these mechanisms, platelets are integral to critical physiological processes such as thrombosis, wound healing, and immune surveillance. However, dysregulated platelet function can contribute to pathological conditions, including cancer metastasis, atherosclerosis, and chronic inflammation. Due to their central involvement in both normal physiology and disease, platelets have become prominent targets for therapeutic intervention. Current treatments primarily aim to modulate platelet signaling to prevent thrombosis in cardiovascular diseases or to reduce excessive platelet aggregation in other pathological conditions. Antiplatelet therapies are widely employed in clinical practice to mitigate clot formation in high-risk patients. As platelet biology continues to evolve, emerging therapeutic strategies focus on refining platelet modulation to enhance clinical outcomes and prevent complications associated with platelet dysfunction. This review explores the structure, signaling pathways, biological functions, and therapeutic potential of platelets, highlighting their roles in both physiological and pathological contexts.<\/jats:p>","DOI":"10.1038\/s41392-025-02198-8","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:01:50Z","timestamp":1747335710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Platelets and diseases: signal transduction and advances in targeted therapy"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5632-9118","authenticated-orcid":false,"given":"Yuchen","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2286-1069","authenticated-orcid":false,"given":"Yidan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4820-8524","authenticated-orcid":false,"given":"Junjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"2198_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3324\/haematol.2019.244350","volume":"105","author":"P Mazzarello","year":"2020","unstructured":"Mazzarello, P. One hundred years of Haematologica. Haematologica 105, 12\u201321 (2020).","journal-title":"Haematologica"},{"key":"2198_CR2","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1182\/blood.2022015568","volume":"140","author":"BK Manne","year":"2022","unstructured":"Manne, B. K. et al. MAPK-interacting kinase 1 regulates platelet production, activation, and thrombosis. Blood 140, 2477\u20132489 (2022).","journal-title":"Blood"},{"key":"2198_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1080\/09537104.2020.1763939","volume":"31","author":"M Tomaiuolo","year":"2020","unstructured":"Tomaiuolo, M., Litvinov, R. I., Weisel, J. W. & Stalker, T. J. Use of electron microscopy to study platelets and thrombi. Platelets 31, 580\u2013588 (2020).","journal-title":"Platelets"},{"key":"2198_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/s41586-023-06436-3","volume":"620","author":"AB Schroer","year":"2023","unstructured":"Schroer, A. B. et al. Platelet factors attenuate inflammation and rescue cognition in ageing. Nature 620, 1071\u20131079 (2023).","journal-title":"Nature"},{"key":"2198_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/09537104.2020.1732321","volume":"31","author":"AO Khan","year":"2020","unstructured":"Khan, A. O. & Pike, J. A. Super-resolution imaging and quantification of megakaryocytes and platelets. Platelets 31, 559\u2013569 (2020).","journal-title":"Platelets"},{"key":"2198_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-642-29423-5_1","volume":"210","author":"JN Thon","year":"2012","unstructured":"Thon, J. N. & Italiano, J. E. Platelets: production, morphology and ultrastructure. Handb. Exp. Pharm. 210, 3\u201322 (2012).","journal-title":"Handb. Exp. Pharm."},{"key":"2198_CR7","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1111\/jth.15035","volume":"18","author":"ME Quach","year":"2020","unstructured":"Quach, M. E. & Li, R. Structure-function of platelet glycoprotein Ib-IX. J. Thromb. Haemost. 18, 3131\u20133141 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR8","doi-asserted-by":"crossref","unstructured":"van den Kerkhof, D. L., van der Meijden, P. E. J., Hackeng, T. M. & Dijkgraaf, I. Exogenous integrin \u03b1IIb\u03b23 inhibitors revisited: past, present and future applications. Int. J. Mol. Sci. 22, 3366 (2021).","DOI":"10.3390\/ijms22073366"},{"key":"2198_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1139\/cjpp-2020-0149","volume":"99","author":"PE Thibeault","year":"2021","unstructured":"Thibeault, P. E. & Ramachandran, R. Biased signaling in platelet G-protein coupled receptors. Can. J. Physiol. Pharm. 99, 255\u2013269 (2021).","journal-title":"Can. J. Physiol. Pharm."},{"key":"2198_CR10","doi-asserted-by":"crossref","unstructured":"Tang, X. et al. Toll-like receptors and thrombopoiesis. Int. J. Mol. Sci. 24, 1010 (2023).","DOI":"10.3390\/ijms24021010"},{"key":"2198_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1702","volume":"13","author":"M Geranpayehvaghei","year":"2021","unstructured":"Geranpayehvaghei, M. et al. Cancer-associated-platelet-inspired nanomedicines for cancer therapy. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 13, e1702 (2021).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"2198_CR12","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.2147\/IJN.S436373","volume":"18","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Platelet-based nanoparticles with stimuli-responsive for anti-tumor therapy. Int. J. Nanomed. 18, 6293\u20136309 (2023).","journal-title":"Int. J. Nanomed."},{"key":"2198_CR13","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1016\/j.jtha.2023.09.013","volume":"21","author":"L Stanger","year":"2023","unstructured":"Stanger, L., Yamaguchi, A. & Holinstat, M. Antiplatelet strategies: past, present, and future. J. Thromb. Haemost. 21, 3317\u20133328 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41569-023-00854-6","volume":"20","author":"M Gawaz","year":"2023","unstructured":"Gawaz, M., Geisler, T. & Borst, O. Current concepts and novel targets for antiplatelet therapy. Nat. Rev. Cardiol. 20, 583\u2013599 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"2198_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102531","volume":"19","author":"M Scherlinger","year":"2020","unstructured":"Scherlinger, M. et al. Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014. Autoimmun. Rev. 19, 102531 (2020).","journal-title":"Autoimmun. Rev."},{"key":"2198_CR16","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3324\/haematol.2020.252908","volume":"105","author":"CL Balduini","year":"2020","unstructured":"Balduini, C. L. 100-Year old Haematologica images: the quarrel about the origin of platelets (I). Haematologica 105, 1169 (2020).","journal-title":"Haematologica"},{"key":"2198_CR17","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3324\/haematol.2020.254011","volume":"105","author":"CL Balduini","year":"2020","unstructured":"Balduini, C. L. 100-Year-old Haematologica images: the quarrel about the origin of platelets (II). Haematologica 105, 1467 (2020).","journal-title":"Haematologica"},{"key":"2198_CR18","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1083\/jcb.147.6.1299","volume":"147","author":"JE Italiano Jr.","year":"1999","unstructured":"Italiano, J. E. Jr., Lecine, P., Shivdasani, R. A. & Hartwig, J. H. Blood platelets are assembled principally at the ends of proplatelet processes produced by differentiated megakaryocytes. J. Cell Biol. 147, 1299\u20131312 (1999).","journal-title":"J. Cell Biol."},{"key":"2198_CR19","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1182\/blood-2018-11-835371","volume":"133","author":"B Psaila","year":"2019","unstructured":"Psaila, B. & Mead, A. J. Single-cell approaches reveal novel cellular pathways for megakaryocyte and erythroid differentiation. Blood 133, 1427\u20131435 (2019).","journal-title":"Blood"},{"key":"2198_CR20","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/nm.3745","volume":"20","author":"RB Day","year":"2014","unstructured":"Day, R. B. & Link, D. C. Megakaryocytes in the hematopoietic stem cell niche. Nat. Med. 20, 1233\u20131234 (2014).","journal-title":"Nat. Med."},{"key":"2198_CR21","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1182\/blood.V81.11.2844.2844","volume":"81","author":"M Ogawa","year":"1993","unstructured":"Ogawa, M. Differentiation and proliferation of hematopoietic stem cells. Blood 81, 2844\u20132853 (1993).","journal-title":"Blood"},{"key":"2198_CR22","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1182\/blood-2007-11-124685","volume":"111","author":"J Tober","year":"2008","unstructured":"Tober, J., McGrath, K. E. & Palis, J. Primitive erythropoiesis and megakaryopoiesis in the yolk sac are independent of c-myb. Blood 111, 2636\u20132639 (2008).","journal-title":"Blood"},{"key":"2198_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.immuni.2015.03.011","volume":"42","author":"G Hoeffel","year":"2015","unstructured":"Hoeffel, G. et al. C-Myb+ erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity 42, 665\u2013678 (2015).","journal-title":"Immunity"},{"key":"2198_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature21706","volume":"544","author":"E Lefran\u00e7ais","year":"2017","unstructured":"Lefran\u00e7ais, E. et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 544, 105\u2013109 (2017).","journal-title":"Nature"},{"key":"2198_CR25","doi-asserted-by":"crossref","unstructured":"Valet, C. et al. Sepsis promotes splenic production of a protective platelet pool with high CD40 ligand expression. J. Clin. Invest. 132, e153920 (2022).","DOI":"10.1172\/JCI153920"},{"key":"2198_CR26","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1182\/bloodadvances.2021006151","volume":"6","author":"IC Becker","year":"2022","unstructured":"Becker, I. C. et al. G6b-B regulates an essential step in megakaryocyte maturation. Blood Adv. 6, 3155\u20133161 (2022).","journal-title":"Blood Adv."},{"key":"2198_CR27","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1182\/blood-2012-08-449272","volume":"121","author":"A Mazharian","year":"2013","unstructured":"Mazharian, A. et al. Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function. Blood 121, 4205\u20134220 (2013).","journal-title":"Blood"},{"key":"2198_CR28","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1182\/blood.V95.12.4004","volume":"95","author":"T Youssefian","year":"2000","unstructured":"Youssefian, T. & Cramer, E. M. Megakaryocyte dense granule components are sorted in multivesicular bodies. Blood 95, 4004\u20134007 (2000).","journal-title":"Blood"},{"key":"2198_CR29","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3324\/haematol.2021.279636","volume":"107","author":"J Lacey","year":"2022","unstructured":"Lacey, J. et al. Sorting nexin 24 is required for \u03b1-granule biogenesis and cargo delivery in megakaryocytes. Haematologica 107, 1902\u20131913 (2022).","journal-title":"Haematologica"},{"key":"2198_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1182\/blood-2014-09-600858","volume":"125","author":"M Bender","year":"2015","unstructured":"Bender, M. et al. Microtubule sliding drives proplatelet elongation and is dependent on cytoplasmic dynein. Blood 125, 860\u2013868 (2015).","journal-title":"Blood"},{"key":"2198_CR31","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1182\/blood-2018-03-791517","volume":"132","author":"T H\u00f6fer","year":"2018","unstructured":"H\u00f6fer, T. & Rodewald, H. R. Differentiation-based model of hematopoietic stem cell functions and lineage pathways. Blood 132, 1106\u20131113 (2018).","journal-title":"Blood"},{"key":"2198_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00062752-200005000-00010","volume":"7","author":"JG Drachman","year":"2000","unstructured":"Drachman, J. G. Role of thrombopoietin in hematopoietic stem cell and progenitor regulation. Curr. Opin. Hematol. 7, 183\u2013190 (2000).","journal-title":"Curr. Opin. Hematol."},{"key":"2198_CR33","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/0092-8674(94)90450-2","volume":"77","author":"TD Bartley","year":"1994","unstructured":"Bartley, T. D. et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77, 1117\u20131124 (1994).","journal-title":"Cell"},{"key":"2198_CR34","doi-asserted-by":"publisher","first-page":"32214","DOI":"10.1074\/jbc.M005080200","volume":"275","author":"Y Miyakawa","year":"2000","unstructured":"Miyakawa, Y. et al. A structure-function analysis of serine\/threonine phosphorylation of the thrombopoietin receptor, c-Mpl. J. Biol. Chem. 275, 32214\u201332219 (2000).","journal-title":"J. Biol. Chem."},{"key":"2198_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1182\/blood.V86.1.23.bloodjournal86123","volume":"86","author":"Y Miyakawa","year":"1995","unstructured":"Miyakawa, Y. et al. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 86, 23\u201327 (1995).","journal-title":"Blood"},{"key":"2198_CR36","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1182\/blood.V89.8.2782","volume":"89","author":"PJ Fielder","year":"1997","unstructured":"Fielder, P. J. et al. Human platelets as a model for the binding and degradation of thrombopoietin. Blood 89, 2782\u20132788 (1997).","journal-title":"Blood"},{"key":"2198_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/bjh.12758","volume":"165","author":"KR Machlus","year":"2014","unstructured":"Machlus, K. R., Thon, J. N. & Italiano, J. E. Jr. Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation. Br. J. Haematol. 165, 227\u2013236 (2014).","journal-title":"Br. J. Haematol."},{"key":"2198_CR38","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.scr.2013.05.007","volume":"11","author":"SY Heazlewood","year":"2013","unstructured":"Heazlewood, S. Y. et al. Megakaryocytes co-localise with hemopoietic stem cells and release cytokines that up-regulate stem cell proliferation. Stem Cell Res. 11, 782\u2013792 (2013).","journal-title":"Stem Cell Res."},{"key":"2198_CR39","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1126\/science.1146304","volume":"317","author":"T Junt","year":"2007","unstructured":"Junt, T. et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 317, 1767\u20131770 (2007).","journal-title":"Science"},{"key":"2198_CR40","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1083\/jcb.201304054","volume":"201","author":"KR Machlus","year":"2013","unstructured":"Machlus, K. R. & Italiano, J. E. Jr. The incredible journey: from megakaryocyte development to platelet formation. J. Cell Biol. 201, 785\u2013796 (2013).","journal-title":"J. Cell Biol."},{"key":"2198_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.thromres.2022.12.004","volume":"231","author":"HE Allan","year":"2023","unstructured":"Allan, H. E., Vadgama, A., Armstrong, P. C. & Warner, T. D. Platelet ageing: a review. Thromb. Res. 231, 214\u2013222 (2023).","journal-title":"Thromb. Res."},{"key":"2198_CR42","first-page":"319","volume":"11","author":"MH Periayah","year":"2017","unstructured":"Periayah, M. H., Halim, A. S. & Mat Saad, A. Z. Mechanism action of platelets and crucial blood coagulation pathways in hemostasis. Int. J. Hematol. Oncol. Stem Cell Res. 11, 319\u2013327 (2017).","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"2198_CR43","doi-asserted-by":"crossref","unstructured":"Roka-Moiia, Y. et al. Shear-mediated platelet microparticles demonstrate phenotypic heterogeneity as to morphology, receptor distribution, and hemostatic function. Int. J. Mol. Sci. 24, 7386 (2023).","DOI":"10.3390\/ijms24087386"},{"key":"2198_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/09537104.2016.1257786","volume":"28","author":"S Yadav","year":"2017","unstructured":"Yadav, S. & Storrie, B. The cellular basis of platelet secretion: emerging structure\/function relationships. Platelets 28, 108\u2013118 (2017).","journal-title":"Platelets"},{"key":"2198_CR45","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1172\/JCI26891","volume":"115","author":"SR Patel","year":"2005","unstructured":"Patel, S. R., Hartwig, J. H. & Italiano, J. E. Jr. The biogenesis of platelets from megakaryocyte proplatelets. J. Clin. Invest. 115, 3348\u20133354 (2005).","journal-title":"J. Clin. Invest."},{"key":"2198_CR46","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1111\/jth.15012","volume":"18","author":"SL French","year":"2020","unstructured":"French, S. L. et al. High-content, label-free analysis of proplatelet production from megakaryocytes. J. Thromb. Haemost. 18, 2701\u20132711 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR47","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1182\/blood-2005-07-2755","volume":"107","author":"H Schulze","year":"2006","unstructured":"Schulze, H. et al. Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis. Blood 107, 3868\u20133875 (2006).","journal-title":"Blood"},{"key":"2198_CR48","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1152\/physrev.00020.2015","volume":"96","author":"EM Bevers","year":"2016","unstructured":"Bevers, E. M. & Williamson, P. L. Getting to the outer leaflet: physiology of phosphatidylserine exposure at the plasma membrane. Physiol. Rev. 96, 605\u2013645 (2016).","journal-title":"Physiol. Rev."},{"key":"2198_CR49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00036.2009","volume":"90","author":"J Saarikangas","year":"2010","unstructured":"Saarikangas, J., Zhao, H. & Lappalainen, P. Regulation of the actin cytoskeleton-plasma membrane interplay by phosphoinositides. Physiol. Rev. 90, 259\u2013289 (2010).","journal-title":"Physiol. Rev."},{"key":"2198_CR50","doi-asserted-by":"crossref","unstructured":"Sorrentino, S. et al. Structural analysis of receptors and actin polarity in platelet protrusions. Proc. Natl Acad. Sci. USA 118, e2105004118 (2021).","DOI":"10.1073\/pnas.2105004118"},{"key":"2198_CR51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1051\/ject\/201749174","volume":"49","author":"GJ Myers","year":"2017","unstructured":"Myers, G. J. & Wegner, J. Endothelial glycocalyx and cardiopulmonary bypass. J. Extra Corpor. Technol. 49, 174\u2013181 (2017).","journal-title":"J. Extra Corpor. Technol."},{"key":"2198_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12265-012-9445-9","volume":"6","author":"G Cimmino","year":"2013","unstructured":"Cimmino, G. & Golino, P. Platelet biology and receptor pathways. J. Cardiovasc. Transl. Res. 6, 299\u2013309 (2013).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"2198_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39763-0","volume":"14","author":"BD Adair","year":"2023","unstructured":"Adair, B. D., Xiong, J. P., Yeager, M. & Arnaout, M. A. Cryo-EM structures of full-length integrin \u03b1IIb\u03b23 in native lipids. Nat. Commun. 14, 4168 (2023).","journal-title":"Nat. Commun."},{"key":"2198_CR54","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673\u2013687 (2002).","journal-title":"Cell"},{"key":"2198_CR55","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4070\/kcj.2012.42.5.295","volume":"42","author":"SJ Joo","year":"2012","unstructured":"Joo, S. J. Mechanisms of platelet activation and integrin \u03b1II\u03b23. Korean Circ. J. 42, 295\u2013301 (2012).","journal-title":"Korean Circ. J."},{"key":"2198_CR56","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(02)00906-6","volume":"110","author":"O Vinogradova","year":"2002","unstructured":"Vinogradova, O. et al. A structural mechanism of integrin alpha(IIb)beta(3) \u201cinside-out\u201d activation as regulated by its cytoplasmic face. Cell 110, 587\u2013597 (2002).","journal-title":"Cell"},{"key":"2198_CR57","doi-asserted-by":"crossref","unstructured":"Zou, J. et al. Reversible platelet integrin \u03b1IIb\u03b23 activation and thrombus instability. Int. J. Mol. Sci. 23, 12512 (2022).","DOI":"10.3390\/ijms232012512"},{"key":"2198_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13045-019-0709-6","volume":"12","author":"J Huang","year":"2019","unstructured":"Huang, J. et al. Platelet integrin \u03b1IIb\u03b23: signal transduction, regulation, and its therapeutic targeting. J. Hematol. Oncol. 12, 26 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"2198_CR59","doi-asserted-by":"crossref","unstructured":"Chaudhary, P. K. et al. Characterization of integrin \u03b1IIb\u03b23-mediated outside-in signaling by protein kinase C\u03b4 in platelets. Int. J. Mol. Sci. 21, 6563 (2020).","DOI":"10.3390\/ijms21186563"},{"key":"2198_CR60","doi-asserted-by":"crossref","unstructured":"Lu, J. et al. Stoichiometry and architecture of the platelet membrane complex glycoprotein Ib-IX-V. Biol. Chem. 405, 91\u2013104 (2023).","DOI":"10.1515\/hsz-2022-0227"},{"key":"2198_CR61","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/MOH.0b013e3280dce51a","volume":"14","author":"X Du","year":"2007","unstructured":"Du, X. Signaling and regulation of the platelet glycoprotein Ib-IX-V complex. Curr. Opin. Hematol. 14, 262\u2013269 (2007).","journal-title":"Curr. Opin. Hematol."},{"key":"2198_CR62","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1161\/CIRCULATIONAHA.105.571315","volume":"112","author":"Y Wang","year":"2005","unstructured":"Wang, Y. et al. Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin Mac-1 is critical for the biological response to vascular injury. Circulation 112, 2993\u20133000 (2005).","journal-title":"Circulation"},{"key":"2198_CR63","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1161\/CIRCRESAHA.109.204669","volume":"105","author":"Y Yuan","year":"2009","unstructured":"Yuan, Y. et al. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Circ. Res. 105, 1177\u20131185 (2009).","journal-title":"Circ. Res."},{"key":"2198_CR64","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1161\/ATVBAHA.112.254920","volume":"32","author":"MK Delaney","year":"2012","unstructured":"Delaney, M. K. et al. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation. Arterioscler. Thromb. Vasc. Biol. 32, 2761\u20132768 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR65","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1182\/blood.V99.1.151","volume":"99","author":"CL Yap","year":"2002","unstructured":"Yap, C. L. et al. Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib\/V\/IX and integrin alpha(IIb)beta(3). Blood 99, 151\u2013158 (2002).","journal-title":"Blood"},{"key":"2198_CR66","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/09537104.2021.1942815","volume":"33","author":"ME Quach","year":"2022","unstructured":"Quach, M. E. GPIb-IX-V and platelet clearance. Platelets 33, 817\u2013822 (2022).","journal-title":"Platelets"},{"key":"2198_CR67","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02207-2","volume":"40","author":"T Ling","year":"2023","unstructured":"Ling, T., Liu, J., Dong, L. & Liu, J. The roles of P-selectin in cancer cachexia. Med. Oncol. 40, 338 (2023).","journal-title":"Med. Oncol."},{"key":"2198_CR68","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1471-4914(03)00071-6","volume":"9","author":"K Ley","year":"2003","unstructured":"Ley, K. The role of selectins in inflammation and disease. Trends Mol. Med. 9, 263\u2013268 (2003).","journal-title":"Trends Mol. Med."},{"key":"2198_CR69","first-page":"948","volume":"20","author":"S Zeng","year":"1999","unstructured":"Zeng, S., Yi, F. X. & Guo, Z. G. Platelet activating factor-induced P-selectin expression in platelets and its related signal transduction. Zhongguo Yao li Xue Bao 20, 948\u2013950 (1999).","journal-title":"Zhongguo Yao li Xue Bao"},{"key":"2198_CR70","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/j.thromres.2010.10.023","volume":"127","author":"A Assinger","year":"2011","unstructured":"Assinger, A. et al. Periodontopathogens induce soluble P-selectin release by endothelial cells and platelets. Thromb. Res. 127, e20\u201326 (2011).","journal-title":"Thromb. Res."},{"key":"2198_CR71","doi-asserted-by":"crossref","unstructured":"Hally, K. et al. Revisiting platelets and toll-like receptors (TLRs): at the interface of vascular immunity and thrombosis. Int. J. Mol. Sci. 21, 6150 (2020).","DOI":"10.3390\/ijms21176150"},{"key":"2198_CR72","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1080\/09537104.2022.2107627","volume":"33","author":"B Williams","year":"2022","unstructured":"Williams, B., Zhu, J., Zou, L. & Chao, W. Innate immune TLR7 signaling mediates platelet activation and platelet-leukocyte aggregate formation in murine bacterial sepsis. Platelets 33, 1251\u20131259 (2022).","journal-title":"Platelets"},{"key":"2198_CR73","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/rheumatology\/kead296","volume":"63","author":"SH Tay","year":"2024","unstructured":"Tay, S. H. et al. Platelet TLR7 is essential for the formation of platelet-neutrophil complexes and low-density neutrophils in lupus nephritis. Rheumatology 63, 551\u2013562 (2024).","journal-title":"Rheumatology"},{"key":"2198_CR74","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3389\/fimmu.2014.00653","volume":"5","author":"MT Rondina","year":"2014","unstructured":"Rondina, M. T. & Garraud, O. Emerging evidence for platelets as immune and inflammatory effector cells. Front. Immunol. 5, 653 (2014).","journal-title":"Front. Immunol."},{"key":"2198_CR75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fimmu.2015.00083","volume":"6","author":"F Cognasse","year":"2015","unstructured":"Cognasse, F. et al. The inflammatory role of platelets via their TLRs and Siglec receptors. Front. Immunol. 6, 83 (2015).","journal-title":"Front. Immunol."},{"key":"2198_CR76","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/JLB.4MR0620-701R","volume":"108","author":"PRB Dib","year":"2020","unstructured":"Dib, P. R. B. et al. Innate immune receptors in platelets and platelet-leukocyte interactions. J. Leukoc. Biol. 108, 1157\u20131182 (2020).","journal-title":"J. Leukoc. Biol."},{"key":"2198_CR77","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrd2518","volume":"7","author":"MC Lagerstr\u00f6m","year":"2008","unstructured":"Lagerstr\u00f6m, M. C. & Schi\u00f6th, H. B. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat. Rev. Drug Discov. 7, 339\u2013357 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2198_CR78","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","volume":"85","author":"N Wettschureck","year":"2005","unstructured":"Wettschureck, N. & Offermanns, S. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85, 1159\u20131204 (2005).","journal-title":"Physiol. Rev."},{"key":"2198_CR79","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00018-004-4462-3","volume":"62","author":"CR McCudden","year":"2005","unstructured":"McCudden, C. R. et al. G-protein signaling: back to the future. Cell Mol. Life Sci. 62, 551\u2013577 (2005).","journal-title":"Cell Mol. Life Sci."},{"key":"2198_CR80","doi-asserted-by":"publisher","first-page":"46035","DOI":"10.1074\/jbc.M208519200","volume":"277","author":"J Yang","year":"2002","unstructured":"Yang, J. et al. Signaling through Gi family members in platelets. Redundancy and specificity in the regulation of adenylyl cyclase and other effectors. J. Biol. Chem. 277, 46035\u201346042 (2002).","journal-title":"J. Biol. Chem."},{"key":"2198_CR81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/38284","volume":"389","author":"S Offermanns","year":"1997","unstructured":"Offermanns, S., Toombs, C. F., Hu, Y. H. & Simon, M. I. Defective platelet activation in G alpha(q)-deficient mice. Nature 389, 183\u2013186 (1997).","journal-title":"Nature"},{"key":"2198_CR82","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/nm943","volume":"9","author":"A Moers","year":"2003","unstructured":"Moers, A. et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat. Med. 9, 1418\u20131422 (2003).","journal-title":"Nat. Med."},{"key":"2198_CR83","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1172\/JCI12818","volume":"108","author":"HM Jantzen","year":"2001","unstructured":"Jantzen, H. M. et al. Impaired activation of murine platelets lacking G alpha(i2). J. Clin. Invest. 108, 477\u2013483 (2001).","journal-title":"J. Clin. Invest."},{"key":"2198_CR84","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1538-7836.2004.00741.x","volume":"2","author":"TM Quinton","year":"2004","unstructured":"Quinton, T. M. et al. Different G protein-coupled signaling pathways are involved in alpha granule release from human platelets. J. Thromb. Haemost. 2, 978\u2013984 (2004).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR85","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/bph.16256","volume":"181","author":"WAE Parker","year":"2024","unstructured":"Parker, W. A. E. & Storey, R. F. The role of platelet P2Y(12) receptors in inflammation. Br. J. Pharm. 181, 515\u2013531 (2024).","journal-title":"Br. J. Pharm."},{"key":"2198_CR86","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1160\/TH12-11-0853","volume":"110","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Contact- and agonist-regulated microvesiculation of human platelets. Thromb. Haemost. 110, 331\u2013339 (2013).","journal-title":"Thromb. Haemost."},{"key":"2198_CR87","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1161\/ATVBAHA.110.207522","volume":"30","author":"Z Li","year":"2010","unstructured":"Li, Z., Delaney, M. K., O\u2019Brien, K. A. & Du, X. Signaling during platelet adhesion and activation. Arterioscler. Thromb. Vasc. Biol. 30, 2341\u20132349 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR88","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/bph.16191","volume":"181","author":"D Pan","year":"2024","unstructured":"Pan, D., Ladds, G., Rahman, K. M. & Pitchford, S. C. Exploring bias in platelet P2Y(1) signalling: host defence versus haemostasis. Br. J. Pharm. 181, 580\u2013592 (2024).","journal-title":"Br. J. Pharm."},{"key":"2198_CR89","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1042\/BJ20141404","volume":"466","author":"R Goggs","year":"2015","unstructured":"Goggs, R., Williams, C. M., Mellor, H. & Poole, A. W. Platelet Rho GTPases-a focus on novel players, roles and relationships. Biochem. J. 466, 431\u2013442 (2015).","journal-title":"Biochem. J."},{"key":"2198_CR90","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1073\/pnas.89.8.3659","volume":"89","author":"F Liao","year":"1992","unstructured":"Liao, F., Shin, H. S. & Rhee, S. G. Tyrosine phosphorylation of phospholipase C-gamma 1 induced by cross-linking of the high-affinity or low-affinity Fc receptor for IgG in U937 cells. Proc. Natl Acad. Sci. USA 89, 3659\u20133663 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2198_CR91","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.advenzreg.2010.09.011","volume":"51","author":"MP Gratacap","year":"2011","unstructured":"Gratacap, M. P. et al. Regulation and roles of PI3K\u03b2, a major actor in platelet signaling and functions. Adv. Enzym. Regul. 51, 106\u2013116 (2011).","journal-title":"Adv. Enzym. Regul."},{"key":"2198_CR92","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1538-7836.2005.01325.x","volume":"3","author":"TM Quinton","year":"2005","unstructured":"Quinton, T. M., Kim, S., Jin, J. & Kunapuli, S. P. Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation. J. Thromb. Haemost. 3, 1036\u20131041 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR93","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1083\/jcb.144.4.745","volume":"144","author":"B Klages","year":"1999","unstructured":"Klages, B. et al. Activation of G12\/G13 results in shape change and Rho\/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J. Cell Biol. 144, 745\u2013754 (1999).","journal-title":"J. Cell Biol."},{"key":"2198_CR94","doi-asserted-by":"publisher","first-page":"28003","DOI":"10.1074\/jbc.274.39.28003","volume":"274","author":"JM Manganello","year":"1999","unstructured":"Manganello, J. M. et al. Cyclic AMP-dependent phosphorylation of thromboxane A(2) receptor-associated Galpha(13). J. Biol. Chem. 274, 28003\u201328010 (1999).","journal-title":"J. Biol. Chem."},{"key":"2198_CR95","doi-asserted-by":"crossref","unstructured":"Renna, S. A., McKenzie, S. E. & Michael, J. V. Species differences in platelet protease-activated receptors. Int. J. Mol. Sci. 24, 8298 (2023).","DOI":"10.3390\/ijms24098298"},{"key":"2198_CR96","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1101\/sqb.2002.67.197","volume":"67","author":"SR Coughlin","year":"2002","unstructured":"Coughlin, S. R. Protease-activated receptors in the cardiovascular system. Cold Spring Harb. Symp. Quant. Biol. 67, 197\u2013208 (2002).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"2198_CR97","doi-asserted-by":"publisher","first-page":"10210","DOI":"10.1074\/jbc.M605678200","volume":"282","author":"JS Huang","year":"2007","unstructured":"Huang, J. S., Dong, L., Kozasa, T. & Le Breton, G. C. Signaling through G(alpha)13 switch region I is essential for protease-activated receptor 1-mediated human platelet shape change, aggregation, and secretion. J. Biol. Chem. 282, 10210\u201310222 (2007).","journal-title":"J. Biol. Chem."},{"key":"2198_CR98","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2008.03.021","volume":"45","author":"N Bakdash","year":"2008","unstructured":"Bakdash, N. & Williams, M. S. Spatially distinct production of reactive oxygen species regulates platelet activation. Free Radic. Biol. Med. 45, 158\u2013166 (2008).","journal-title":"Free Radic. Biol. Med."},{"key":"2198_CR99","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns, P. et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113, 3716\u20133725 (2009).","journal-title":"Blood"},{"key":"2198_CR100","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1182\/blood.2020004974","volume":"136","author":"I Melki","year":"2020","unstructured":"Melki, I. et al. Fc\u03b3RIIA expression accelerates nephritis and increases platelet activation in systemic lupus erythematosus. Blood 136, 2933\u20132945 (2020).","journal-title":"Blood"},{"key":"2198_CR101","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MOH.0000000000000239","volume":"23","author":"P Lertkiatmongkol","year":"2016","unstructured":"Lertkiatmongkol, P. et al. Endothelial functions of platelet\/endothelial cell adhesion molecule-1 (CD31). Curr. Opin. Hematol. 23, 253\u2013259 (2016).","journal-title":"Curr. Opin. Hematol."},{"key":"2198_CR102","first-page":"4082","volume":"20","author":"YM Feng","year":"2016","unstructured":"Feng, Y. M., Chen, X. H. & Zhang, X. Roles of PECAM-1 in cell function and disease progression. Riv. Eur. Sci. Med. Farmacol. 20, 4082\u20134088 (2016).","journal-title":"Riv. Eur. Sci. Med. Farmacol."},{"key":"2198_CR103","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1172\/JCI117442","volume":"94","author":"TG Diacovo","year":"1994","unstructured":"Diacovo, T. G., deFougerolles, A. R., Bainton, D. F. & Springer, T. A. A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2. J. Clin. Invest. 94, 1243\u20131251 (1994).","journal-title":"J. Clin. Invest."},{"key":"2198_CR104","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1023\/B:IFLA.0000049042.73926.eb","volume":"28","author":"KS Weber","year":"2004","unstructured":"Weber, K. S., Alon, R. & Klickstein, L. B. Sialylation of ICAM-2 on platelets impairs adhesion of leukocytes via LFA-1 and DC-SIGN. Inflammation 28, 177\u2013188 (2004).","journal-title":"Inflammation"},{"key":"2198_CR105","doi-asserted-by":"crossref","unstructured":"Suzuki-Inoue, K. Roles of the CLEC-2-podoplanin interaction in tumor progression. Platelets 29, 786\u2013792 (2018).","DOI":"10.1080\/09537104.2018.1478401"},{"key":"2198_CR106","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1074\/jbc.M110.167502","volume":"286","author":"S S\u00e9verin","year":"2011","unstructured":"S\u00e9verin, S. et al. Syk-dependent phosphorylation of CLEC-2: a novel mechanism of hem-immunoreceptor tyrosine-based activation motif signaling. J. Biol. Chem. 286, 4107\u20134116 (2011).","journal-title":"J. Biol. Chem."},{"key":"2198_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12710","volume":"6","author":"C Dangelmaier","year":"2022","unstructured":"Dangelmaier, C. et al. Clustering extent-dependent differential signaling by CLEC-2 receptors in platelets. Res. Pr. Thromb. Haemost. 6, e12710 (2022).","journal-title":"Res. Pr. Thromb. Haemost."},{"key":"2198_CR108","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.cellsig.2010.03.001","volume":"22","author":"JM Bradshaw","year":"2010","unstructured":"Bradshaw, J. M. The Src, Syk, and Tec family kinases: distinct types of molecular switches. Cell Signal 22, 1175\u20131184 (2010).","journal-title":"Cell Signal"},{"key":"2198_CR109","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bcp.2014.11.005","volume":"93","author":"BK Manne","year":"2015","unstructured":"Manne, B. K., Badolia, R., Dangelmaier, C. A. & Kunapuli, S. P. C-type lectin like receptor 2 (CLEC-2) signals independently of lipid raft microdomains in platelets. Biochem. Pharm. 93, 163\u2013170 (2015).","journal-title":"Biochem. Pharm."},{"key":"2198_CR110","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.it.2011.09.004","volume":"32","author":"Y Baba","year":"2011","unstructured":"Baba, Y. & Kurosaki, T. Impact of Ca2+ signaling on B cell function. Trends Immunol. 32, 589\u2013594 (2011).","journal-title":"Trends Immunol."},{"key":"2198_CR111","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.jtha.2023.03.022","volume":"21","author":"PH Mangin","year":"2023","unstructured":"Mangin, P. H., Gardiner, E. E., Ari\u00ebns, R. A. S. & Jandrot-Perrus, M. Glycoprotein VI interplay with fibrin(ogen) in thrombosis. J. Thromb. Haemost. 21, 1703\u20131713 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR112","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jtha.2022.09.004","volume":"21","author":"JS Gauer","year":"2023","unstructured":"Gauer, J. S. et al. Fibrin-glycoprotein VI interaction increases platelet procoagulant activity and impacts clot structure. J. Thromb. Haemost. 21, 667\u2013681 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR113","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1111\/j.1538-7836.2012.04814.x","volume":"10","author":"S S\u00e9verin","year":"2012","unstructured":"S\u00e9verin, S. et al. Distinct and overlapping functional roles of Src family kinases in mouse platelets. J. Thromb. Haemost. 10, 1631\u20131645 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR114","doi-asserted-by":"publisher","first-page":"37520","DOI":"10.1074\/jbc.M305077200","volume":"278","author":"P Wonerow","year":"2003","unstructured":"Wonerow, P., Pearce, A. C., Vaux, D. J. & Watson, S. P. A critical role for phospholipase Cgamma2 in alphaIIbbeta3-mediated platelet spreading. J. Biol. Chem. 278, 37520\u201337529 (2003).","journal-title":"J. Biol. Chem."},{"key":"2198_CR115","doi-asserted-by":"publisher","first-page":"33750","DOI":"10.1074\/jbc.M109.048439","volume":"284","author":"K Gilio","year":"2009","unstructured":"Gilio, K. et al. Non-redundant roles of phosphoinositide 3-kinase isoforms \u03b1 and \u03b2 in glycoprotein VI-induced platelet signaling and thrombus formation. J. Biol. Chem. 284, 33750\u201333762 (2009).","journal-title":"J. Biol. Chem."},{"key":"2198_CR116","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1182\/blood-2002-04-1234","volume":"100","author":"L Leo","year":"2002","unstructured":"Leo, L. et al. Role of the adapter protein SLP-76 in GPVI-dependent platelet procoagulant responses to collagen. Blood 100, 2839\u20132844 (2002).","journal-title":"Blood"},{"key":"2198_CR117","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1182\/blood-2008-07-169268","volume":"113","author":"B Nagy","year":"2009","unstructured":"Nagy, B. et al. Impaired activation of platelets lacking protein kinase C-\u03b8 isoform. Blood 113, 2557\u20132567 (2009).","journal-title":"Blood"},{"key":"2198_CR118","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/j.1538-7836.2012.04857.x","volume":"10","author":"AJ Unsworth","year":"2012","unstructured":"Unsworth, A. J. et al. Protein kinase C\u03b5 and protein kinase C\u03b8 double-deficient mice have a bleeding diathesis. J. Thromb. Haemost. 10, 1887\u20131894 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR119","unstructured":"Kholmukhamedov, A., Rae, J. & Jobe, S. M. Cytoplasmic phospholipase A2 is essential in GPVI signaling initiated procoagulant platelet formation. Blood 130, 1068 (2017)."},{"key":"2198_CR120","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1042\/bj2950725","volume":"295","author":"MA Kowalska","year":"1993","unstructured":"Kowalska, M. A. & Tuszynski, G. P. Interaction of thrombospondin with platelet glycoproteins GPIa-IIa and GPIIb-IIIa. Biochem. J. 295, 725\u2013730 (1993).","journal-title":"Biochem. J."},{"key":"2198_CR121","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1055\/s-0043-1768935","volume":"50","author":"G Bendas","year":"2024","unstructured":"Bendas, G. & Schlesinger, M. The role of CD36\/GPIV in platelet biology. Semin. Thromb. Hemost. 50, 224\u2013235 (2024).","journal-title":"Semin. Thromb. Hemost."},{"key":"2198_CR122","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/ATVBAHA.123.318341","volume":"43","author":"E Mammadova-Bach","year":"2023","unstructured":"Mammadova-Bach, E., Gudermann, T. & Braun, A. Platelet mechanotransduction: regulatory cross talk between mechanosensitive receptors and calcium channels. Arterioscler. Thromb. Vasc. Biol. 43, 1339\u20131348 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR123","doi-asserted-by":"publisher","first-page":"28164","DOI":"10.1074\/jbc.M104161200","volume":"276","author":"B Yan","year":"2001","unstructured":"Yan, B., Calderwood, D. A., Yaspan, B. & Ginsberg, M. H. Calpain cleavage promotes talin binding to the beta 3 integrin cytoplasmic domain. J. Biol. Chem. 276, 28164\u201328170 (2001).","journal-title":"J. Biol. Chem."},{"key":"2198_CR124","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fcvm.2019.00153","volume":"6","author":"H Melchinger","year":"2019","unstructured":"Melchinger, H., Jain, K., Tyagi, T. & Hwa, J. Role of platelet mitochondria: life in a nucleus-free zone. Front. Cardiovasc. Med. 6, 153 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"2198_CR125","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/labinvest.2013.53","volume":"93","author":"BK Chacko","year":"2013","unstructured":"Chacko, B. K. et al. Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Lab. Invest. 93, 690\u2013700 (2013).","journal-title":"Lab. Invest."},{"key":"2198_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113312","volume":"42","author":"TR Richman","year":"2023","unstructured":"Richman, T. R. et al. Mitochondrial gene expression is required for platelet function and blood clotting. Cell Rep. 42, 113312 (2023).","journal-title":"Cell Rep."},{"key":"2198_CR127","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/CIRCRESAHA.123.322914","volume":"134","author":"S Jacob","year":"2024","unstructured":"Jacob, S. et al. Mitofusin-2 regulates platelet mitochondria and function. Circ. Res. 134, 143\u2013161 (2024).","journal-title":"Circ. Res."},{"key":"2198_CR128","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1161\/ATVBAHA.117.309184","volume":"37","author":"TP Fidler","year":"2017","unstructured":"Fidler, T. P. et al. Glucose transporter 3 potentiates degranulation and is required for platelet activation. Arterioscler. Thromb. Vasc. Biol. 37, 1628\u20131639 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR129","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201321RR","volume":"37","author":"PP Kulkarni","year":"2023","unstructured":"Kulkarni, P. P. et al. Fatty acid oxidation fuels agonist-induced platelet activation and thrombus formation: targeting \u03b2-oxidation of fatty acids as an effective anti-platelet strategy. FASEB J. 37, e22768 (2023).","journal-title":"FASEB J."},{"key":"2198_CR130","doi-asserted-by":"publisher","first-page":"e0123597","DOI":"10.1371\/journal.pone.0123597","volume":"10","author":"S Ravi","year":"2015","unstructured":"Ravi, S. et al. Metabolic plasticity in resting and thrombin activated platelets. PLoS ONE 10, e0123597 (2015).","journal-title":"PLoS ONE"},{"key":"2198_CR131","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.1182\/bloodadvances.2023010423","volume":"7","author":"A Grichine","year":"2023","unstructured":"Grichine, A. et al. The fate of mitochondria during platelet activation. Blood Adv. 7, 6290\u20136302 (2023).","journal-title":"Blood Adv."},{"key":"2198_CR132","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1182\/bloodadvances.2023010100","volume":"7","author":"GD Flora","year":"2023","unstructured":"Flora, G. D. et al. Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis. Blood Adv. 7, 2347\u20132359 (2023).","journal-title":"Blood Adv."},{"key":"2198_CR133","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.redox.2013.12.026","volume":"2","author":"PA Kramer","year":"2014","unstructured":"Kramer, P. A. et al. A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers. Redox Biol. 2, 206\u2013210 (2014).","journal-title":"Redox Biol."},{"key":"2198_CR134","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11033-023-09116-7","volume":"51","author":"D Shehwar","year":"2024","unstructured":"Shehwar, D. et al. Inhibition of mitochondrial calcium transporters alters adp-induced platelet responses. Mol. Biol. Rep. 51, 177 (2024).","journal-title":"Mol. Biol. Rep."},{"key":"2198_CR135","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1016\/j.bbrc.2018.08.031","volume":"503","author":"AP Sowton","year":"2018","unstructured":"Sowton, A. P., Millington-Burgess, S. L., Murray, A. J. & Harper, M. T. Rapid kinetics of changes in oxygen consumption rate in thrombin-stimulated platelets measured by high-resolution respirometry. Biochem. Biophys. Res. Commun. 503, 2721\u20132727 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2198_CR136","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10059-011-0276-3","volume":"32","author":"YS Bae","year":"2011","unstructured":"Bae, Y. S., Oh, H., Rhee, S. G. & Yoo, Y. D. Regulation of reactive oxygen species generation in cell signaling. Mol. Cells 32, 491\u2013509 (2011).","journal-title":"Mol. Cells"},{"key":"2198_CR137","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1042\/BST20120327","volume":"41","author":"S Zharikov","year":"2013","unstructured":"Zharikov, S. & Shiva, S. Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease. Biochem. Soc. Trans. 41, 118\u2013123 (2013).","journal-title":"Biochem. Soc. Trans."},{"key":"2198_CR138","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0891-5849(96)00488-1","volume":"22","author":"L Iuliano","year":"1997","unstructured":"Iuliano, L. et al. Oxygen free radicals and platelet activation. Free Radic. Biol. Med. 22, 999\u20131006 (1997).","journal-title":"Free Radic. Biol. Med."},{"key":"2198_CR139","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1042\/bj20011672","volume":"367","author":"GP McStay","year":"2002","unstructured":"McStay, G. P., Clarke, S. J. & Halestrap, A. P. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem. J. 367, 541\u2013548 (2002).","journal-title":"Biochem. J."},{"key":"2198_CR140","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s12026-015-8760-z","volume":"64","author":"J Qiao","year":"2016","unstructured":"Qiao, J. et al. Imbalanced expression of Bcl-xL and Bax in platelets treated with plasma from immune thrombocytopenia. Immunol. Res. 64, 604\u2013609 (2016).","journal-title":"Immunol. Res."},{"key":"2198_CR141","doi-asserted-by":"publisher","first-page":"e75044","DOI":"10.1371\/journal.pone.0075044","volume":"8","author":"Z Wang","year":"2013","unstructured":"Wang, Z. et al. The role of mitochondria-derived reactive oxygen species in hyperthermia-induced platelet apoptosis. PLoS ONE 8, e75044 (2013).","journal-title":"PLoS ONE"},{"key":"2198_CR142","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/j.1538-7836.2007.02505.x","volume":"5","author":"JJ Lopez","year":"2007","unstructured":"Lopez, J. J. et al. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J. Thromb. Haemost. 5, 1283\u20131291 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR143","doi-asserted-by":"publisher","first-page":"11087","DOI":"10.3390\/ijms160511087","volume":"16","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Mitochondria-derived reactive oxygen species play an important role in Doxorubicin-induced platelet apoptosis. Int. J. Mol. Sci. 16, 11087\u201311100 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"2198_CR144","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1182\/blood-2007-05-092684","volume":"111","author":"SM Jobe","year":"2008","unstructured":"Jobe, S. M. et al. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood 111, 1257\u20131265 (2008).","journal-title":"Blood"},{"key":"2198_CR145","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.1190217","volume":"330","author":"D Ren","year":"2010","unstructured":"Ren, D. et al. BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330, 1390\u20131393 (2010).","journal-title":"Science"},{"key":"2198_CR146","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/cdd.2011.100","volume":"18","author":"A Villunger","year":"2011","unstructured":"Villunger, A. et al. Can the analysis of BH3-only protein knockout mice clarify the issue of \u2018direct versus indirect\u2019 activation of Bax and Bak? Cell Death Differ. 18, 1545\u20131546 (2011).","journal-title":"Cell Death Differ."},{"key":"2198_CR147","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.biocel.2014.02.015","volume":"50","author":"LF Garcia-Souza","year":"2014","unstructured":"Garcia-Souza, L. F. & Oliveira, M. F. Mitochondria: biological roles in platelet physiology and pathology. Int. J. Biochem. Cell Biol. 50, 156\u2013160 (2014).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2198_CR148","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.thromres.2022.11.024","volume":"231","author":"EC Josefsson","year":"2023","unstructured":"Josefsson, E. C. Platelet intrinsic apoptosis. Thromb. Res. 231, 206\u2013213 (2023).","journal-title":"Thromb. Res."},{"key":"2198_CR149","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","volume":"128","author":"KD Mason","year":"2007","unstructured":"Mason, K. D. et al. Programmed anuclear cell death delimits platelet life span. Cell 128, 1173\u20131186 (2007).","journal-title":"Cell"},{"key":"2198_CR150","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1182\/blood-2009-12-259663","volume":"116","author":"MR Dowling","year":"2010","unstructured":"Dowling, M. R. et al. Platelet senescence is regulated by an internal timer, not damage inflicted by hits. Blood 116, 1776\u20131778 (2010).","journal-title":"Blood"},{"key":"2198_CR151","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2014-05-573543","volume":"124","author":"LH Boudreau","year":"2014","unstructured":"Boudreau, L. H. et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 124, 2173\u20132183 (2014).","journal-title":"Blood"},{"key":"2198_CR152","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1111\/trf.17524","volume":"63","author":"M Pelletier","year":"2023","unstructured":"Pelletier, M. et al. Platelet extracellular vesicles and their mitochondrial content improve the mitochondrial bioenergetics of cellular immune recipients. Transfusion 63, 1983\u20131996 (2023).","journal-title":"Transfusion"},{"key":"2198_CR153","doi-asserted-by":"crossref","unstructured":"Yu, H., Hu, W., Song, X. & Zhao, Y. Immune modulation of platelet-derived mitochondria on memory CD4+ T cells in humans. Int. J. Mol. Sci. 21, 6295 (2020).","DOI":"10.3390\/ijms21176295"},{"key":"2198_CR154","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cmet.2021.02.003","volume":"33","author":"J Levoux","year":"2021","unstructured":"Levoux, J. et al. Platelets facilitate the wound-healing capability of mesenchymal stem cells by mitochondrial transfer and metabolic reprogramming. Cell Metab. 33, 688\u2013690 (2021).","journal-title":"Cell Metab."},{"key":"2198_CR155","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrrheum.2018.38","volume":"14","author":"P Linge","year":"2018","unstructured":"Linge, P. et al. The non-haemostatic role of platelets in systemic lupus erythematosus. Nat. Rev. Rheumatol. 14, 195\u2013213 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2198_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1210509","volume":"14","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. Platelet mitochondria, a potent immune mediator in neurological diseases. Front. Physiol. 14, 1210509 (2023).","journal-title":"Front. Physiol."},{"key":"2198_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113147","volume":"42","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondria. Cell Rep. 42, 113147 (2023).","journal-title":"Cell Rep."},{"key":"2198_CR158","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00424-022-02763-y","volume":"475","author":"ZJ Lin","year":"2023","unstructured":"Lin, Z. J. et al. Human platelet mitochondria improve the mitochondrial and cardiac function of donor heart. Pflug. Arch. 475, 267\u2013275 (2023).","journal-title":"Pflug. Arch."},{"key":"2198_CR159","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1042\/CS20200530","volume":"134","author":"H Ma","year":"2020","unstructured":"Ma, H. et al. Transplantation of platelet-derived mitochondria alleviates cognitive impairment and mitochondrial dysfunction in db\/db mice. Clin. Sci. 134, 2161\u20132175 (2020).","journal-title":"Clin. Sci."},{"key":"2198_CR160","doi-asserted-by":"publisher","first-page":"963689721102421","DOI":"10.1177\/09636897211024210","volume":"30","author":"C Shi","year":"2021","unstructured":"Shi, C., Guo, H. & Liu, X. Platelet mitochondria transplantation rescues hypoxia\/reoxygenation-induced mitochondrial dysfunction and neuronal cell death involving the FUNDC2\/PIP3\/Akt\/FOXO3a axis. Cell Transpl. 30, 9636897211024210 (2021).","journal-title":"Cell Transpl."},{"key":"2198_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-016-0481-4","volume":"11","author":"C Qin","year":"2016","unstructured":"Qin, C. et al. Platelets activation is associated with elevated plasma mitochondrial DNA during cardiopulmonary bypass. J. Cardiothorac. Surg. 11, 90 (2016).","journal-title":"J. Cardiothorac. Surg."},{"key":"2198_CR162","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.molimm.2021.07.007","volume":"137","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. Monomeric C-reactive protein promotes platelets to release mitochondrial DNA in anti-neutrophil cytoplasmic antibody-associated vasculitis. Mol. Immunol. 137, 228\u2013237 (2021).","journal-title":"Mol. Immunol."},{"key":"2198_CR163","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/trf.13373","volume":"56","author":"F Cognasse","year":"2016","unstructured":"Cognasse, F. et al. Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers. Transfusion 56, 497\u2013504 (2016).","journal-title":"Transfusion"},{"key":"2198_CR164","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.2147\/NDT.S229284","volume":"15","author":"Q He","year":"2019","unstructured":"He, Q. et al. Thromboelastography with platelet mapping detects platelet dysfunction in patients with aneurysmal subarachnoid hemorrhage with rebleeding. Neuropsychiatr. Dis. Treat. 15, 3443\u20133451 (2019).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"2198_CR165","doi-asserted-by":"publisher","first-page":"111725","DOI":"10.1016\/j.mad.2022.111725","volume":"207","author":"TR Li","year":"2022","unstructured":"Li, T. R. & Liu, F. Q. \u03b2-Amyloid promotes platelet activation and activated platelets act as bridge between risk factors and Alzheimer\u2019s disease. Mech. Ageing Dev. 207, 111725 (2022).","journal-title":"Mech. Ageing Dev."},{"key":"2198_CR166","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neulet.2006.07.006","volume":"405","author":"CW Shults","year":"2006","unstructured":"Shults, C. W., Barrett, J. M. & Fontaine, D. alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson\u2019s disease and multiple system atrophy. Neurosci. Lett. 405, 223\u2013225 (2006).","journal-title":"Neurosci. Lett."},{"key":"2198_CR167","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1111\/jth.15107","volume":"18","author":"F Denorme","year":"2020","unstructured":"Denorme, F. et al. COVID-19 patients exhibit reduced procoagulant platelet responses. J. Thromb. Haemost. 18, 3067\u20133073 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR168","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2147\/NDT.S188964","volume":"15","author":"M Zv\u011b\u0159ov\u00e1","year":"2019","unstructured":"Zv\u011b\u0159ov\u00e1, M. et al. Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder. Neuropsychiatr. Dis. Treat. 15, 233\u2013240 (2019).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"2198_CR169","doi-asserted-by":"crossref","unstructured":"Donner, L. et al. Impact of amyloid-\u03b2 on platelet mitochondrial function and platelet-mediated amyloid aggregation in Alzheimer\u2019s disease. Int. J. Mol. Sci. 22, 9633 (2021).","DOI":"10.3390\/ijms22179633"},{"key":"2198_CR170","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1681\/ASN.2015060661","volume":"27","author":"A Tin","year":"2016","unstructured":"Tin, A. et al. Association between mitochondrial DNA copy number in peripheral blood and incident CKD in the atherosclerosis risk in communities study. J. Am. Soc. Nephrol. 27, 2467\u20132473 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2198_CR171","doi-asserted-by":"publisher","first-page":"131606","DOI":"10.1016\/j.ijcard.2023.131606","volume":"398","author":"N Peng","year":"2024","unstructured":"Peng, N. et al. Platelet mitochondrial DNA methylation: a novel biomarker for myocardial infarction\u2014a preliminary study. Int. J. Cardiol. 398, 131606 (2024).","journal-title":"Int. J. Cardiol."},{"key":"2198_CR172","doi-asserted-by":"publisher","first-page":"236","DOI":"10.12688\/f1000research.13283.1","volume":"7","author":"A Sharda","year":"2018","unstructured":"Sharda, A. & Flaumenhaft, R. The life cycle of platelet granules. F1000Research 7, 236 (2018).","journal-title":"F1000Research"},{"key":"2198_CR173","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-cellbio-111315-125125","volume":"32","author":"RM Perera","year":"2016","unstructured":"Perera, R. M. & Zoncu, R. The lysosome as a regulatory hub. Annu. Rev. Cell Dev. Biol. 32, 223\u2013253 (2016).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"2198_CR174","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1084952102000599","volume":"13","author":"SM King","year":"2002","unstructured":"King, S. M. & Reed, G. L. Development of platelet secretory granules. Semin. Cell Dev. Biol. 13, 293\u2013302 (2002).","journal-title":"Semin. Cell Dev. Biol."},{"key":"2198_CR175","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3109\/09537104.2010.499156","volume":"21","author":"Z Simon","year":"2010","unstructured":"Simon, Z. et al. Protein phosphatase inhibitor calyculin-A modulates activation markers in TRAP-stimulated human platelets. Platelets 21, 555\u2013562 (2010).","journal-title":"Platelets"},{"key":"2198_CR176","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/09537100500235958","volume":"17","author":"C Emiliani","year":"2006","unstructured":"Emiliani, C. et al. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders. Platelets 17, 20\u201329 (2006).","journal-title":"Platelets"},{"key":"2198_CR177","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1182\/blood.V96.5.1782","volume":"96","author":"D Chen","year":"2000","unstructured":"Chen, D., Lemons, P. P., Schraw, T. & Whiteheart, S. W. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 and 4 in lysosome release. Blood 96, 1782\u20131788 (2000).","journal-title":"Blood"},{"key":"2198_CR178","first-page":"46","volume":"56","author":"OCW Chen","year":"2020","unstructured":"Chen, O. C. W. et al. Defective platelet function in Niemann-Pick disease type C1. JIMD Rep. 56, 46\u201357 (2020).","journal-title":"JIMD Rep."},{"key":"2198_CR179","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/pcmr.12051","volume":"26","author":"AH Wei","year":"2013","unstructured":"Wei, A. H. & Li, W. Hermansky-Pudlak syndrome: pigmentary and non-pigmentary defects and their pathogenesis. Pigment Cell Melanoma Res. 26, 176\u2013192 (2013).","journal-title":"Pigment Cell Melanoma Res."},{"key":"2198_CR180","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1538-7836.2009.03387.x","volume":"7","author":"JE Italiano Jr.","year":"2009","unstructured":"Italiano, J. E. Jr. & Battinelli, E. M. Selective sorting of alpha-granule proteins. J. Thromb. Haemost. 7, 173\u2013176 (2009).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR181","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1055\/s-2007-995836","volume":"24","author":"JG White","year":"1998","unstructured":"White, J. G. Use of the electron microscope for diagnosis of platelet disorders. Semin. Thromb. Hemost. 24, 163\u2013168 (1998).","journal-title":"Semin. Thromb. Hemost."},{"key":"2198_CR182","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/jth.13225","volume":"14","author":"ID Pokrovskaya","year":"2016","unstructured":"Pokrovskaya, I. D. et al. STEM tomography reveals that the canalicular system and \u03b1-granules remain separate compartments during early secretion stages in blood platelets. J. Thromb. Haemost. 14, 572\u2013584 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111735","volume":"386","author":"M Zhuang","year":"2020","unstructured":"Zhuang, M. et al. Exogenous carbon monoxide suppresses LPS-induced platelet SNAREs complex assembly and \u03b1-granule exocytosis via integrin \u03b1IIb\u03b23-Mediated PKC\u03b8\/Munc18a pathway. Exp. Cell Res. 386, 111735 (2020).","journal-title":"Exp. Cell Res."},{"key":"2198_CR184","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1182\/bloodadvances.2018020834","volume":"3","author":"EM Battinelli","year":"2019","unstructured":"Battinelli, E. M. et al. Megakaryocytes package contents into separate \u03b1-granules that are differentially distributed in platelets. Blood Adv. 3, 3092\u20133098 (2019).","journal-title":"Blood Adv."},{"key":"2198_CR185","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1111\/j.1538-7836.2007.02690.x","volume":"5","author":"DM Maynard","year":"2007","unstructured":"Maynard, D. M. et al. Proteomic analysis of platelet alpha-granules using mass spectrometry. J. Thromb. Haemost. 5, 1945\u20131955 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR186","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1016\/S0049-3848(16)30372-3","volume":"141","author":"XR Xu","year":"2016","unstructured":"Xu, X. R., Gallant, R. C. & Ni, H. Platelets, immune-mediated thrombocytopenias, and fetal hemorrhage. Thromb. Res. 141, S76\u2013S79 (2016).","journal-title":"Thromb. Res."},{"key":"2198_CR187","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00018-014-1743-8","volume":"72","author":"M Bryckaert","year":"2015","unstructured":"Bryckaert, M., Rosa, J. P., Denis, C. V. & Lenting, P. J. Of von Willebrand factor and platelets. Cell Mol. Life Sci. 72, 307\u2013326 (2015).","journal-title":"Cell Mol. Life Sci."},{"key":"2198_CR188","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fphys.2015.00290","volume":"6","author":"CE Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez, C. E., Smith, P. C. & Palma Alvarado, V. A. The influence of platelet-derived products on angiogenesis and tissue repair: a concise update. Front. Physiol. 6, 290 (2015).","journal-title":"Front. Physiol."},{"key":"2198_CR189","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cytogfr.2021.11.003","volume":"64","author":"E Cecerska-Hery\u0107","year":"2022","unstructured":"Cecerska-Hery\u0107, E. et al. Applications of the regenerative capacity of platelets in modern medicine. Cytokine Growth Factor Rev. 64, 84\u201394 (2022).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2198_CR190","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ijlh.14075","volume":"45","author":"A Greinacher","year":"2023","unstructured":"Greinacher, A. & Warkentin, T. E. Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity. Int. J. Lab. Hematol. 45, 11\u201322 (2023).","journal-title":"Int. J. Lab. Hematol."},{"key":"2198_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101155","volume":"64","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Platelet factor 4(PF4) and its multiple roles in diseases. Blood Rev. 64, 101155 (2024).","journal-title":"Blood Rev."},{"key":"2198_CR192","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12272-020-01296-1","volume":"44","author":"D Anka Idrissi","year":"2021","unstructured":"Anka Idrissi, D. et al. IL-1 and CD40\/CD40L platelet complex: elements of induction of Crohn\u2019s disease and new therapeutic targets. Arch. Pharm. Res. 44, 117\u2013132 (2021).","journal-title":"Arch. Pharm. Res."},{"key":"2198_CR193","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10787-015-0229-0","volume":"23","author":"S Jinesh","year":"2015","unstructured":"Jinesh, S. Pharmaceutical aspects of anti-inflammatory TNF-blocking drugs. Inflammopharmacology 23, 71\u201377 (2015).","journal-title":"Inflammopharmacology"},{"key":"2198_CR194","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/beha.1999.0029","volume":"12","author":"CT Esmon","year":"1999","unstructured":"Esmon, C. T. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. Baillieres Best. Pract. Res. Clin. Haematol. 12, 343\u2013359 (1999).","journal-title":"Baillieres Best. Pract. Res. Clin. Haematol."},{"key":"2198_CR195","doi-asserted-by":"publisher","first-page":"1276353","DOI":"10.3389\/fimmu.2023.1276353","volume":"14","author":"J Leberzammer","year":"2023","unstructured":"Leberzammer, J. & von Hundelshausen, P. Chemokines, molecular drivers of thromboinflammation and immunothrombosis. Front. Immunol. 14, 1276353 (2023).","journal-title":"Front. Immunol."},{"key":"2198_CR196","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-0039-1701017","volume":"46","author":"AE John","year":"2020","unstructured":"John, A. E. & White, N. J. Platelets and fibrinogen: emerging complexity in trauma-induced coagulopathy. Semin. Thromb. Hemost. 46, 125\u2013133 (2020).","journal-title":"Semin. Thromb. Hemost."},{"key":"2198_CR197","doi-asserted-by":"crossref","unstructured":"Hulshof, A. M. et al. Thrombin-fibrin(ogen) interactions, host defense and risk of thrombosis. Int. J. Mol. Sci. 22, 2590 (2021).","DOI":"10.3390\/ijms22052590"},{"key":"2198_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100733","volume":"46","author":"Y Sang","year":"2021","unstructured":"Sang, Y. et al. Interplay between platelets and coagulation. Blood Rev. 46, 100733 (2021).","journal-title":"Blood Rev."},{"key":"2198_CR199","doi-asserted-by":"publisher","first-page":"2337907","DOI":"10.1080\/09537104.2024.2337907","volume":"35","author":"FS Alshehri","year":"2024","unstructured":"Alshehri, F. S., Bashmeil, A. A., Alamar, I. A. & Alouda, S. K. The natural anticoagulant protein S; hemostatic functions and deficiency. Platelets 35, 2337907 (2024).","journal-title":"Platelets"},{"key":"2198_CR200","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/path.1871","volume":"208","author":"BA Lwaleed","year":"2006","unstructured":"Lwaleed, B. A. & Bass, P. S. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J. Pathol. 208, 327\u2013339 (2006).","journal-title":"J. Pathol."},{"key":"2198_CR201","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/hh2401.101272","volume":"89","author":"U Sch\u00f6nbeck","year":"2001","unstructured":"Sch\u00f6nbeck, U. & Libby, P. CD40 signaling and plaque instability. Circ. Res. 89, 1092\u20131103 (2001).","journal-title":"Circ. Res."},{"key":"2198_CR202","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1182\/blood-2006-12-027698","volume":"109","author":"SP Jackson","year":"2007","unstructured":"Jackson, S. P. The growing complexity of platelet aggregation. Blood 109, 5087\u20135095 (2007).","journal-title":"Blood"},{"key":"2198_CR203","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1182\/blood-2015-02-629717","volume":"126","author":"E Mammadova-Bach","year":"2015","unstructured":"Mammadova-Bach, E. et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood 126, 683\u2013691 (2015).","journal-title":"Blood"},{"key":"2198_CR204","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/MBC.0b013e3283358116","volume":"21","author":"J Morales","year":"2010","unstructured":"Morales, J. et al. Soluble TLT-1 modulates platelet-endothelial cell interactions and actin polymerization. Blood Coagul. Fibrinolysis 21, 229\u2013236 (2010).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"2198_CR205","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/09537104.2021.1881948","volume":"32","author":"S Branfield","year":"2021","unstructured":"Branfield, S. & Washington, A. V. The enigmatic nature of the triggering receptor expressed in myeloid cells -1 (TLT- 1). Platelets 32, 753\u2013760 (2021).","journal-title":"Platelets"},{"key":"2198_CR206","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1111\/bph.15476","volume":"178","author":"E Rawish","year":"2021","unstructured":"Rawish, E. et al. Complement, inflammation and thrombosis. Br. J. Pharm. 178, 2892\u20132904 (2021).","journal-title":"Br. J. Pharm."},{"key":"2198_CR207","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1055\/s-0041-1725065","volume":"47","author":"Y Nadir","year":"2021","unstructured":"Nadir, Y. Effect of heparanase and heparan sulfate chains in hemostasis. Semin. Thromb. Hemost. 47, 254\u2013260 (2021).","journal-title":"Semin. Thromb. Hemost."},{"key":"2198_CR208","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.alit.2023.04.004","volume":"72","author":"T Miyata","year":"2023","unstructured":"Miyata, T. & Horiuchi, T. Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency. Allergol. Int. 72, 375\u2013384 (2023).","journal-title":"Allergol. Int."},{"key":"2198_CR209","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fimmu.2020.00044","volume":"11","author":"S Maurer","year":"2020","unstructured":"Maurer, S., Kopp, H. G., Salih, H. R. & Kropp, K. N. Modulation of immune responses by platelet-derived ADAM10. Front. Immunol. 11, 44 (2020).","journal-title":"Front. Immunol."},{"key":"2198_CR210","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/bs.pmbts.2017.01.002","volume":"147","author":"P Gresele","year":"2017","unstructured":"Gresele, P., Falcinelli, E., Sebastiano, M. & Momi, S. Matrix metalloproteinases and platelet function. Prog. Mol. Biol. Transl. Sci. 147, 133\u2013165 (2017).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"2198_CR211","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/09537104.2021.1913576","volume":"33","author":"CW Smith","year":"2022","unstructured":"Smith, C. W. Release of \u03b1-granule contents during platelet activation. Platelets 33, 491\u2013502 (2022).","journal-title":"Platelets"},{"key":"2198_CR212","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1161\/ATVBAHA.113.301147","volume":"33","author":"P Wijten","year":"2013","unstructured":"Wijten, P. et al. High precision platelet releasate definition by quantitative reversed protein profiling-brief report. Arterioscler. Thromb. Vasc. Biol. 33, 1635\u20131638 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR213","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/cvr\/cvu113","volume":"103","author":"TC van Holten","year":"2014","unstructured":"van Holten, T. C. et al. Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets. Cardiovasc. Res. 103, 140\u2013146 (2014).","journal-title":"Cardiovasc. Res."},{"key":"2198_CR214","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1055\/s-0037-1616219","volume":"86","author":"B Furie","year":"2001","unstructured":"Furie, B., Furie, B. C. & Flaumenhaft, R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb. Haemost. 86, 214\u2013221 (2001).","journal-title":"Thromb. Haemost."},{"key":"2198_CR215","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1182\/blood.V87.4.1385.bloodjournal8741385","volume":"87","author":"G Berger","year":"1996","unstructured":"Berger, G., Mass\u00e9, J. M. & Cramer, E. M. Alpha-granule membrane mirrors the platelet plasma membrane and contains the glycoproteins Ib, IX, and V. Blood 87, 1385\u20131395 (1996).","journal-title":"Blood"},{"key":"2198_CR216","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/jth.15243","volume":"19","author":"H Chanzu","year":"2021","unstructured":"Chanzu, H. et al. Platelet \u03b1-granule cargo packaging and release are affected by the luminal proteoglycan, serglycin. J. Thromb. Haemost. 19, 1082\u20131095 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR217","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.thromres.2015.09.008","volume":"136","author":"X Xu","year":"2015","unstructured":"Xu, X. & Sun, B. Platelet granule secretion mechanisms: are they modified in sepsis? Thromb. Res. 136, 845\u2013850 (2015).","journal-title":"Thromb. Res."},{"key":"2198_CR218","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1091\/mbc.e06-09-0785","volume":"18","author":"Q Ren","year":"2007","unstructured":"Ren, Q. et al. Endobrevin\/VAMP-8 is the primary v-SNARE for the platelet release reaction. Mol. Biol. Cell 18, 24\u201333 (2007).","journal-title":"Mol. Biol. Cell"},{"key":"2198_CR219","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1182\/blood-2012-07-442756","volume":"120","author":"MS Marks","year":"2012","unstructured":"Marks, M. S. SNARing platelet granule secretion. Blood 120, 2355\u20132357 (2012).","journal-title":"Blood"},{"key":"2198_CR220","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/MOH.0b013e3283632e6b","volume":"20","author":"S Koseoglu","year":"2013","unstructured":"Koseoglu, S. & Flaumenhaft, R. Advances in platelet granule biology. Curr. Opin. Hematol. 20, 464\u2013471 (2013).","journal-title":"Curr. Opin. Hematol."},{"key":"2198_CR221","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ceb.2010.04.006","volume":"22","author":"CM Carr","year":"2010","unstructured":"Carr, C. M. & Rizo, J. At the junction of SNARE and SM protein function. Curr. Opin. Cell Biol. 22, 488\u2013495 (2010).","journal-title":"Curr. Opin. Cell Biol."},{"key":"2198_CR222","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1055\/s-0040-1718733","volume":"121","author":"K Neubauer","year":"2021","unstructured":"Neubauer, K. et al. Impaired platelet function in Sept8-deficient mice in vitro. Thromb. Haemost. 121, 484\u2013494 (2021).","journal-title":"Thromb. Haemost."},{"key":"2198_CR223","doi-asserted-by":"crossref","unstructured":"Dupuis, A., Bordet, J. C., Eckly, A. & Gachet, C. Platelet \u03b4-storage pool disease: an update. J. Clin. Med. 9, 2508 (2020).","DOI":"10.3390\/jcm9082508"},{"key":"2198_CR224","first-page":"633","volume":"87","author":"JM Gerrard","year":"1977","unstructured":"Gerrard, J. M., Rao, G. H. & White, J. G. The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets. Am. J. Pathol. 87, 633\u2013646 (1977).","journal-title":"Am. J. Pathol."},{"key":"2198_CR225","doi-asserted-by":"crossref","unstructured":"Chen, Y., Yuan, Y. & Li, W. Sorting machineries: how platelet-dense granules differ from \u03b1-granules. Biosci. Rep. 38, BSR20180458 (2018).","DOI":"10.1042\/BSR20180458"},{"key":"2198_CR226","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/09537104.2016.1243789","volume":"28","author":"AL Ambrosio","year":"2017","unstructured":"Ambrosio, A. L. & Di Pietro, S. M. Storage pool diseases illuminate platelet dense granule biogenesis. Platelets 28, 138\u2013146 (2017).","journal-title":"Platelets"},{"key":"2198_CR227","doi-asserted-by":"crossref","unstructured":"Gianazza, E. et al. Platelets in healthy and disease states: from biomarkers discovery to drug targets identification by proteomics. Int. J. Mol. Sci. 21, 4541 (2020).","DOI":"10.3390\/ijms21124541"},{"key":"2198_CR228","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/09537104.2018.1431388","volume":"29","author":"MV Selvadurai","year":"2018","unstructured":"Selvadurai, M. V. & Hamilton, J. R. Structure and function of the open canalicular system\u2014the platelet\u2019s specialized internal membrane network. Platelets 29, 319\u2013325 (2018).","journal-title":"Platelets"},{"key":"2198_CR229","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1182\/blood.V85.2.402.402","volume":"85","author":"ES Choi","year":"1995","unstructured":"Choi, E. S. et al. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 85, 402\u2013413 (1995).","journal-title":"Blood"},{"key":"2198_CR230","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1182\/blood-2010-02-268680","volume":"116","author":"H van Nispen tot Pannerden","year":"2010","unstructured":"van Nispen tot Pannerden, H. et al. The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes. Blood 116, 1147\u20131156 (2010).","journal-title":"Blood"},{"key":"2198_CR231","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/ATVBAHA.123.319099","volume":"43","author":"M Brambilla","year":"2023","unstructured":"Brambilla, M. et al. Cell surface platelet tissue factor expression: regulation by P2Y(12) and link to residual platelet reactivity. Arterioscler. Thromb. Vasc. Biol. 43, 2042\u20132057 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR232","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1111\/jth.13147","volume":"13","author":"H Heijnen","year":"2015","unstructured":"Heijnen, H. & van der Sluijs, P. Platelet secretory behaviour: as diverse as the granules \u2026 or not? J. Thromb. Haemost. 13, 2141\u20132151 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR233","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0002-9440(10)65530-7","volume":"155","author":"JG White","year":"1999","unstructured":"White, J. G., Krumwiede, M. D. & Escolar, G. Glycoprotein Ib is homogeneously distributed on external and internal membranes of resting platelets. Am. J. Pathol. 155, 2127\u20132134 (1999).","journal-title":"Am. J. Pathol."},{"key":"2198_CR234","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/S0049-3848(08)70017-3","volume":"122","author":"G Escolar","year":"2008","unstructured":"Escolar, G. et al. Internalization of tissue factor by platelets. Thromb. Res. 122, S37\u2013S41 (2008).","journal-title":"Thromb. Res."},{"key":"2198_CR235","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1182\/blood.V99.11.4006","volume":"99","author":"D Feng","year":"2002","unstructured":"Feng, D. et al. Subcellular distribution of 3 functional platelet SNARE proteins: human cellubrevin, SNAP-23, and syntaxin 2. Blood 99, 4006\u20134014 (2002).","journal-title":"Blood"},{"key":"2198_CR236","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1007\/s12274-020-2912-8","volume":"13","author":"D Cabrera","year":"2020","unstructured":"Cabrera, D. et al. Controlling human platelet activation with calcium-binding nanoparticles. Nano Res. 13, 2697\u20132705 (2020).","journal-title":"Nano Res."},{"key":"2198_CR237","doi-asserted-by":"publisher","DOI":"10.1002\/phy2.85","volume":"1","author":"SO Sage","year":"2013","unstructured":"Sage, S. O., Pugh, N., Farndale, R. W. & Harper, A. G. Pericellular Ca2+ recycling potentiates thrombin-evoked Ca2+ signals in human platelets. Physiol. Rep. 1, e00085 (2013).","journal-title":"Physiol. Rep."},{"key":"2198_CR238","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1055\/s-0038-1648656","volume":"40","author":"JM Gerrard","year":"1978","unstructured":"Gerrard, J. M., White, J. G. & Peterson, D. A. The platelet dense tubular system: its relationship to prostaglandin synthesis and calcium flux. Thromb. Haemost. 40, 224\u2013231 (1978).","journal-title":"Thromb. Haemost."},{"key":"2198_CR239","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/157340641202160208195923","volume":"12","author":"P Davlouros","year":"2016","unstructured":"Davlouros, P. et al. Role of calcium in platelet activation: novel insights and pharmacological implications. Med. Chem. 12, 131\u2013138 (2016).","journal-title":"Med. Chem."},{"key":"2198_CR240","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.bpj.2014.03.028","volume":"106","author":"AT Dolan","year":"2014","unstructured":"Dolan, A. T. & Diamond, S. L. Systems modeling of Ca2+ homeostasis and mobilization in platelets mediated by IP3 and store-operated Ca2+ entry. Biophys. J. 106, 2049\u20132060 (2014).","journal-title":"Biophys. J."},{"key":"2198_CR241","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF00316071","volume":"97","author":"AL Gonz\u00e1lez-Utor","year":"1992","unstructured":"Gonz\u00e1lez-Utor, A. L., S\u00e1nchez-Aguayo, I. & Hidalgo, J. Cytochemical localization of K+-dependent p-nitrophenyl phosphatase and adenylate cyclase by using one-step method in human washed platelets. Histochemistry 97, 503\u2013507 (1992).","journal-title":"Histochemistry"},{"key":"2198_CR242","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ceca.2018.11.005","volume":"77","author":"E Mammadova-Bach","year":"2019","unstructured":"Mammadova-Bach, E. et al. Store-operated calcium entry in thrombosis and thrombo-inflammation. Cell Calcium 77, 39\u201348 (2019).","journal-title":"Cell Calcium"},{"key":"2198_CR243","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/08830185.2023.2225551","volume":"43","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Platelet extracellular vesicles: darkness and light of autoimmune diseases. Int. Rev. Immunol. 43, 63\u201373 (2024).","journal-title":"Int. Rev. Immunol."},{"key":"2198_CR244","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1055\/s-0042-1756705","volume":"49","author":"M Mabrouk","year":"2023","unstructured":"Mabrouk, M. et al. The pathophysiological role of platelet-derived extracellular vesicles. Semin. Thromb. Hemost. 49, 279\u2013283 (2023).","journal-title":"Semin. Thromb. Hemost."},{"key":"2198_CR245","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/jth.12767","volume":"13","author":"N Arraud","year":"2015","unstructured":"Arraud, N., Gounou, C., Linares, R. & Brisson, A. R. A simple flow cytometry method improves the detection of phosphatidylserine-exposing extracellular vesicles. J. Thromb. Haemost. 13, 237\u2013247 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR246","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.tibtech.2020.10.004","volume":"39","author":"J Johnson","year":"2021","unstructured":"Johnson, J. et al. Prospective therapeutic applications of platelet extracellular vesicles. Trends Biotechnol. 39, 598\u2013612 (2021).","journal-title":"Trends Biotechnol."},{"key":"2198_CR247","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.addr.2021.03.017","volume":"173","author":"SAA Kooijmans","year":"2021","unstructured":"Kooijmans, S. A. A., de Jong, O. G. & Schiffelers, R. M. Exploring interactions between extracellular vesicles and cells for innovative Drug Deliv system design. Adv. Drug Deliv. Rev. 173, 252\u2013278 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2198_CR248","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.thromres.2010.01.036","volume":"125","author":"JM Freyssinet","year":"2010","unstructured":"Freyssinet, J. M. & Toti, F. Formation of procoagulant microparticles and properties. Thromb. Res. 125, S46\u2013S48 (2010).","journal-title":"Thromb. Res."},{"key":"2198_CR249","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1160\/TH12-11-0817","volume":"109","author":"SF Mause","year":"2013","unstructured":"Mause, S. F. Platelet microparticles: reinforcing the hegemony of platelets in atherothrombosis. Thromb. Haemost. 109, 5\u20136 (2013).","journal-title":"Thromb. Haemost."},{"key":"2198_CR250","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.4103\/1673-5374.335825","volume":"17","author":"L Liu","year":"2022","unstructured":"Liu, L. & Deng, Q. J. Role of platelet-derived extracellular vesicles in traumatic brain injury-induced coagulopathy and inflammation. Neural Regen. Res. 17, 2102\u20132107 (2022).","journal-title":"Neural Regen. Res."},{"key":"2198_CR251","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-981-99-1443-2_17","volume":"1418","author":"MT Harper","year":"2023","unstructured":"Harper, M. T. Platelet-derived extracellular vesicles in arterial thrombosis. Adv. Exp. Med. Biol. 1418, 259\u2013275 (2023).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2198_CR252","doi-asserted-by":"crossref","unstructured":"Eustes, A. S. & Dayal, S. The role of platelet-derived extracellular vesicles in immune-mediated thrombosis. Int. J. Mol. Sci. 23, 7837 (2022).","DOI":"10.3390\/ijms23147837"},{"key":"2198_CR253","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jprot.2015.03.013","volume":"121","author":"M Milioli","year":"2015","unstructured":"Milioli, M. et al. Quantitative proteomics analysis of platelet-derived microparticles reveals distinct protein signatures when stimulated by different physiological agonists. J. Proteom. 121, 56\u201366 (2015).","journal-title":"J. Proteom."},{"key":"2198_CR254","doi-asserted-by":"publisher","first-page":"39","DOI":"10.34172\/apb.2021.005","volume":"11","author":"M Nazari","year":"2021","unstructured":"Nazari, M. et al. Platelet microparticle controversial role in cancer. Adv. Pharm. Bull. 11, 39\u201355 (2021).","journal-title":"Adv. Pharm. Bull."},{"key":"2198_CR255","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1007\/s11033-022-08025-5","volume":"50","author":"M Li","year":"2023","unstructured":"Li, M. et al. Roles of the cytoskeleton in human diseases. Mol. Biol. Rep. 50, 2847\u20132856 (2023).","journal-title":"Mol. Biol. Rep."},{"key":"2198_CR256","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1055\/s-0041-1731717","volume":"122","author":"S Mbiandjeu","year":"2022","unstructured":"Mbiandjeu, S., Balduini, A. & Malara, A. Megakaryocyte cytoskeletal proteins in platelet biogenesis and diseases. Thromb. Haemost. 122, 666\u2013678 (2022).","journal-title":"Thromb. Haemost."},{"key":"2198_CR257","doi-asserted-by":"crossref","unstructured":"Cuenca-Zamora, E. J., Ferrer-Mar\u00edn, F., Rivera, J. & Teruel-Montoya, R. Tubulin in platelets: when the shape matters. Int. J. Mol. Sci. 20, 3484 (2019).","DOI":"10.3390\/ijms20143484"},{"key":"2198_CR258","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/MBC.0b013e328364c379","volume":"24","author":"D Cerecedo","year":"2013","unstructured":"Cerecedo, D. Platelet cytoskeleton and its hemostatic role. Blood Coagul. Fibrinolysis 24, 798\u2013808 (2013).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"2198_CR259","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1182\/blood-2007-10-118844","volume":"111","author":"S Patel-Hett","year":"2008","unstructured":"Patel-Hett, S. et al. Visualization of microtubule growth in living platelets reveals a dynamic marginal band with multiple microtubules. Blood 111, 4605\u20134616 (2008).","journal-title":"Blood"},{"key":"2198_CR260","doi-asserted-by":"publisher","DOI":"10.1038\/srep06746","volume":"4","author":"Z Zhao","year":"2014","unstructured":"Zhao, Z. et al. Molecular evolution and functional divergence of tubulin superfamily in the fungal tree of life. Sci. Rep. 4, 6746 (2014).","journal-title":"Sci. Rep."},{"key":"2198_CR261","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0960-9822(01)00153-1","volume":"11","author":"HD Schwer","year":"2001","unstructured":"Schwer, H. D. et al. A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets. Curr. Biol. 11, 579\u2013586 (2001).","journal-title":"Curr. Biol."},{"key":"2198_CR262","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1083\/jcb.201306085","volume":"204","author":"B Diagouraga","year":"2014","unstructured":"Diagouraga, B. et al. Motor-driven marginal band coiling promotes cell shape change during platelet activation. J. Cell Biol. 204, 177\u2013185 (2014).","journal-title":"J. Cell Biol."},{"key":"2198_CR263","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/09537104.2018.1481937","volume":"30","author":"M Zuidscherwoude","year":"2019","unstructured":"Zuidscherwoude, M., Green, H. L. H. & Thomas, S. G. Formin proteins in megakaryocytes and platelets: regulation of actin and microtubule dynamics. Platelets 30, 23\u201330 (2019).","journal-title":"Platelets"},{"key":"2198_CR264","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/jcb.24546","volume":"114","author":"D Cerecedo","year":"2013","unstructured":"Cerecedo, D. et al. Haemostatic role of intermediate filaments in adhered platelets: importance of the membranous system stability. J. Cell Biochem. 114, 2050\u20132060 (2013).","journal-title":"J. Cell Biochem."},{"key":"2198_CR265","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44183-6","volume":"9","author":"Y Schurr","year":"2019","unstructured":"Schurr, Y., Spindler, M., Kurz, H. & Bender, M. The cytoskeletal crosslinking protein MACF1 is dispensable for thrombus formation and hemostasis. Sci. Rep. 9, 7726 (2019).","journal-title":"Sci. Rep."},{"key":"2198_CR266","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1182\/bloodadvances.2019001303","volume":"4","author":"IC Becker","year":"2020","unstructured":"Becker, I. C. et al. Actin\/microtubule crosstalk during platelet biogenesis in mice is critically regulated by Twinfilin1 and Cofilin1. Blood Adv. 4, 2124\u20132134 (2020).","journal-title":"Blood Adv."},{"key":"2198_CR267","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/BF00266758","volume":"96","author":"H Suzuki","year":"1991","unstructured":"Suzuki, H., Tanoue, K. & Yamazaki, H. Morphological evidence for the association of plasma membrane glycoprotein IIb\/IIIa with the membrane skeleton in human platelets. Histochemistry 96, 31\u201339 (1991).","journal-title":"Histochemistry"},{"key":"2198_CR268","first-page":"267","volume":"56","author":"JG White","year":"1969","unstructured":"White, J. G. The submembrane filaments of blood platelets. Am. J. Pathol. 56, 267\u2013277 (1969).","journal-title":"Am. J. Pathol."},{"key":"2198_CR269","doi-asserted-by":"crossref","unstructured":"Scridon, A. Platelets and their role in hemostasis and thrombosis-from physiology to pathophysiology and therapeutic implications. Int. J. Mol. Sci. 23, 12772 (2022).","DOI":"10.3390\/ijms232112772"},{"key":"2198_CR270","doi-asserted-by":"crossref","unstructured":"Chaudhary, P. K., Kim, S. & Kim, S. An insight into recent advances on platelet function in health and disease. Int. J. Mol. Sci. 23, 6022 (2022).","DOI":"10.3390\/ijms23116022"},{"key":"2198_CR271","doi-asserted-by":"crossref","unstructured":"Mereweather, L. J., Constantinescu-Bercu, A., Crawley, J. T. B. & Salles-Crawley, I. I. Platelet-neutrophil crosstalk in thrombosis. Int. J. Mol. Sci. 24, 1266 (2023).","DOI":"10.3390\/ijms24021266"},{"key":"2198_CR272","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1161\/CIRCRESAHA.117.310939","volume":"122","author":"RC Becker","year":"2018","unstructured":"Becker, R. C., Sexton, T. & Smyth, S. S. Translational implications of platelets as vascular first responders. Circ. Res. 122, 506\u2013522 (2018).","journal-title":"Circ. Res."},{"key":"2198_CR273","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1074\/jbc.271.10.5545","volume":"271","author":"L Cavallini","year":"1996","unstructured":"Cavallini, L., Coassin, M., Borean, A. & Alexandre, A. Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J. Biol. Chem. 271, 5545\u20135551 (1996).","journal-title":"J. Biol. Chem."},{"key":"2198_CR274","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1055\/a-1659-6214","volume":"122","author":"E Janus-Bell","year":"2022","unstructured":"Janus-Bell, E. et al. Characterization of the role of integrin \u03b15\u03b21 in platelet function, hemostasis, and experimental thrombosis. Thromb. Haemost. 122, 767\u2013776 (2022).","journal-title":"Thromb. Haemost."},{"key":"2198_CR275","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1084\/jem.187.3.329","volume":"187","author":"T Bombeli","year":"1998","unstructured":"Bombeli, T., Schwartz, B. R. & Harlan, J. M. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. J. Exp. Med. 187, 329\u2013339 (1998).","journal-title":"J. Exp. Med."},{"key":"2198_CR276","doi-asserted-by":"crossref","unstructured":"Hoermann, H. et al. The proteoglycan biglycan modulates platelet adhesion and thrombus formation in a GPVI-dependent manner. Int. J. Mol. Sci. 22, 12168 (2021).","DOI":"10.3390\/ijms222212168"},{"key":"2198_CR277","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1055\/s-0037-1616227","volume":"86","author":"SR Coughlin","year":"2001","unstructured":"Coughlin, S. R. Protease-activated receptors in vascular biology. Thromb. Haemost. 86, 298\u2013307 (2001).","journal-title":"Thromb. Haemost."},{"key":"2198_CR278","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1161\/CIRCULATIONAHA.107.696732","volume":"119","author":"MJ Price","year":"2009","unstructured":"Price, M. J. Bedside evaluation of thienopyridine antiplatelet therapy. Circulation 119, 2625\u20132632 (2009).","journal-title":"Circulation"},{"key":"2198_CR279","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood.2020005382","volume":"137","author":"A Aburima","year":"2021","unstructured":"Aburima, A. et al. Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets. Blood 137, 678\u2013689 (2021).","journal-title":"Blood"},{"key":"2198_CR280","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/10409230903193307","volume":"44","author":"B Fadeel","year":"2009","unstructured":"Fadeel, B. & Xue, D. The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease. Crit. Rev. Biochem. Mol. Biol. 44, 264\u2013277 (2009).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"2198_CR281","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1016\/j.jtha.2023.06.010","volume":"21","author":"O Oshinowo","year":"2023","unstructured":"Oshinowo, O., Azer, S. S., Lin, J. & Lam, W. A. Why platelet mechanotransduction matters for hemostasis and thrombosis. J. Thromb. Haemost. 21, 2339\u20132353 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR282","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10555-017-9677-x","volume":"36","author":"M Holinstat","year":"2017","unstructured":"Holinstat, M. Normal platelet function. Cancer Metastasis Rev. 36, 195\u2013198 (2017).","journal-title":"Cancer Metastasis Rev."},{"key":"2198_CR283","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4103\/0019-5049.144643","volume":"58","author":"S Palta","year":"2014","unstructured":"Palta, S., Saroa, R. & Palta, A. Overview of the coagulation system. Indian J. Anaesth. 58, 515\u2013523 (2014).","journal-title":"Indian J. Anaesth."},{"key":"2198_CR284","doi-asserted-by":"publisher","first-page":"107602962312136","DOI":"10.1177\/10760296231213632","volume":"29","author":"OM Mereuta","year":"2023","unstructured":"Mereuta, O. M. et al. Shell versus core architecture and biology of thrombi in acute ischemic stroke: a systematic review. Clin. Appl. Thromb. Hemost. 29, 10760296231213632 (2023).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"2198_CR285","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1182\/blood.2020007252","volume":"136","author":"ED Hottz","year":"2020","unstructured":"Hottz, E. D. et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood 136, 1330\u20131341 (2020).","journal-title":"Blood"},{"key":"2198_CR286","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/MOH.0000000000000551","volume":"27","author":"L Nicolai","year":"2020","unstructured":"Nicolai, L. & Massberg, S. Platelets as key players in inflammation and infection. Curr. Opin. Hematol. 27, 34\u201340 (2020).","journal-title":"Curr. Opin. Hematol."},{"key":"2198_CR287","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/jth.13955","volume":"16","author":"R Palankar","year":"2018","unstructured":"Palankar, R. et al. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and Fc\u03b3RIIA. J. Thromb. Haemost. 16, 1187\u20131197 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR288","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/jth.12730","volume":"12","author":"JM Herter","year":"2014","unstructured":"Herter, J. M., Rossaint, J. & Zarbock, A. Platelets in inflammation and immunity. J. Thromb. Haemost. 12, 1764\u20131775 (2014).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR289","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cca.2020.04.042","volume":"507","author":"J Chen","year":"2020","unstructured":"Chen, J. & Tan, W. Platelet activation and immune response in diabetic microangiopathy. Clin. Chim. Acta 507, 242\u2013247 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"2198_CR290","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3892\/etm.2021.10554","volume":"22","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. Platelet-derived extracellular vesicles promote the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes via CXCR2 signaling. Exp. Ther. Med. 22, 1120 (2021).","journal-title":"Exp. Ther. Med."},{"key":"2198_CR291","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11239-020-02295-1","volume":"52","author":"MA Plas\u00edn-Rodr\u00edguez","year":"2021","unstructured":"Plas\u00edn-Rodr\u00edguez, M. A. et al. Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus. J. Thromb. Thrombolysis 52, 30\u201341 (2021).","journal-title":"J. Thromb. Thrombolysis"},{"key":"2198_CR292","doi-asserted-by":"crossref","unstructured":"Hasse, S. et al. Red blood cell-derived phosphatidylserine positive extracellular vesicles are associated with past thrombotic events in patients with systemic erythematous lupus. Lupus Sci. Med. 9, e000605 (2022).","DOI":"10.1136\/lupus-2021-000605"},{"key":"2198_CR293","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3389\/fimmu.2019.01478","volume":"10","author":"F Cognasse","year":"2019","unstructured":"Cognasse, F. et al. Platelet inflammatory response to stress. Front. Immunol. 10, 1478 (2019).","journal-title":"Front. Immunol."},{"key":"2198_CR294","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imr.13178","volume":"314","author":"BH Segal","year":"2023","unstructured":"Segal, B. H. et al. Neutrophil interactions with T cells, platelets, endothelial cells, and of course tumor cells. Immunol. Rev. 314, 13\u201335 (2023).","journal-title":"Immunol. Rev."},{"key":"2198_CR295","doi-asserted-by":"publisher","first-page":"e0240164","DOI":"10.1371\/journal.pone.0240164","volume":"15","author":"FW Lam","year":"2020","unstructured":"Lam, F. W. et al. The vimentin rod domain blocks P-selectin-P-selectin glycoprotein ligand 1 interactions to attenuate leukocyte adhesion to inflamed endothelium. PLoS ONE 15, e0240164 (2020).","journal-title":"PLoS ONE"},{"key":"2198_CR296","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12975-021-00938-w","volume":"13","author":"AM Kollikowski","year":"2022","unstructured":"Kollikowski, A. M. et al. Platelet activation and chemokine release are related to local neutrophil-dominant inflammation during hyperacute human stroke. Transl. Stroke Res. 13, 364\u2013369 (2022).","journal-title":"Transl. Stroke Res."},{"key":"2198_CR297","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1182\/blood.2020009428","volume":"138","author":"DJ Wong","year":"2021","unstructured":"Wong, D. J. et al. A PSGL-1 glycomimetic reduces thrombus burden without affecting hemostasis. Blood 138, 1182\u20131193 (2021).","journal-title":"Blood"},{"key":"2198_CR298","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/art.41926","volume":"74","author":"AA Manfredi","year":"2022","unstructured":"Manfredi, A. A. et al. Platelet phagocytosis via P-selectin glycoprotein ligand 1 and accumulation of microparticles in systemic sclerosis. Arthritis Rheumatol. 74, 318\u2013328 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"2198_CR299","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm1565","volume":"13","author":"SR Clark","year":"2007","unstructured":"Clark, S. R. et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463\u2013469 (2007).","journal-title":"Nat. Med."},{"key":"2198_CR300","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.immuni.2023.02.015","volume":"56","author":"M Yang","year":"2023","unstructured":"Yang, M. et al. STING activation in platelets aggravates septic thrombosis by enhancing platelet activation and granule secretion. Immunity 56, 1013\u20131026.e1016 (2023).","journal-title":"Immunity"},{"key":"2198_CR301","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/SHK.0000000000001619","volume":"55","author":"G Fu","year":"2021","unstructured":"Fu, G. et al. Platelet-monocyte aggregates: understanding mechanisms and functions in sepsis. Shock 55, 156\u2013166 (2021).","journal-title":"Shock"},{"key":"2198_CR302","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/ATVBAHA.113.302919","volume":"34","author":"S Badrnya","year":"2014","unstructured":"Badrnya, S. et al. Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation. Arterioscler. Thromb. Vasc. Biol. 34, 571\u2013580 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR303","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1172\/JCI117921","volume":"95","author":"AS Weyrich","year":"1995","unstructured":"Weyrich, A. S. et al. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J. Clin. Invest. 95, 2297\u20132303 (1995).","journal-title":"J. Clin. Invest."},{"key":"2198_CR304","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.4049\/jimmunol.1201103","volume":"191","author":"S Gudbrandsdottir","year":"2013","unstructured":"Gudbrandsdottir, S., Hasselbalch, H. C. & Nielsen, C. H. Activated platelets enhance IL-10 secretion and reduce TNF-\u03b1 secretion by monocytes. J. Immunol. 191, 4059\u20134067 (2013).","journal-title":"J. Immunol."},{"key":"2198_CR305","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz1580","volume":"6","author":"P Han","year":"2020","unstructured":"Han, P. et al. Platelet P-selectin initiates cross-presentation and dendritic cell differentiation in blood monocytes. Sci. Adv. 6, eaaz1580 (2020).","journal-title":"Sci. Adv."},{"key":"2198_CR306","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1160\/TH11-01-0020","volume":"106","author":"N Gerdes","year":"2011","unstructured":"Gerdes, N. et al. Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humans. Thromb. Haemost. 106, 353\u2013362 (2011).","journal-title":"Thromb. Haemost."},{"key":"2198_CR307","doi-asserted-by":"publisher","first-page":"22342","DOI":"10.3390\/ijms151222342","volume":"15","author":"C Aloui","year":"2014","unstructured":"Aloui, C. et al. The signaling role of CD40 ligand in platelet biology and in platelet component transfusion. Int. J. Mol. Sci. 15, 22342\u201322364 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"2198_CR308","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1182\/blood-2007-05-091728","volume":"111","author":"BD Elzey","year":"2008","unstructured":"Elzey, B. D. et al. Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood 111, 3684\u20133691 (2008).","journal-title":"Blood"},{"key":"2198_CR309","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00018-022-04279-1","volume":"79","author":"Y Min","year":"2022","unstructured":"Min, Y. et al. Platelets fine-tune effector responses of na\u00efve CD4+ T cells via platelet factor 4-regulated transforming growth factor \u03b2 signaling. Cell Mol. Life Sci. 79, 247 (2022).","journal-title":"Cell Mol. Life Sci."},{"key":"2198_CR310","doi-asserted-by":"crossref","unstructured":"Scherlinger, M. et al. Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis. Sci. Transl. Med. 13, eabi4994 (2021).","DOI":"10.1126\/scitranslmed.abi4994"},{"key":"2198_CR311","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s12026-017-8951-x","volume":"65","author":"DJ Field","year":"2017","unstructured":"Field, D. J. et al. Platelet factor 4 increases bone marrow B cell development and differentiation. Immunol. Res. 65, 1089\u20131094 (2017).","journal-title":"Immunol. Res."},{"key":"2198_CR312","doi-asserted-by":"crossref","unstructured":"Uchiyama, R. et al. Effect of platelet-rich plasma on M1\/M2 macrophage polarization. Int. J. Mol. Sci. 22, 2336 (2021).","DOI":"10.3390\/ijms22052336"},{"key":"2198_CR313","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/JPER.19-0216","volume":"91","author":"J Nasirzade","year":"2020","unstructured":"Nasirzade, J. et al. Platelet-rich fibrin elicits an anti-inflammatory response in macrophages in vitro. J. Periodontol. 91, 244\u2013252 (2020).","journal-title":"J. Periodontol."},{"key":"2198_CR314","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/humrep\/dex014","volume":"32","author":"Y Du","year":"2017","unstructured":"Du, Y., Liu, X. & Guo, S. W. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms. Hum. Reprod. 32, 794\u2013810 (2017).","journal-title":"Hum. Reprod."},{"key":"2198_CR315","doi-asserted-by":"crossref","unstructured":"Ma, S. et al. PDGF-D-PDGFR\u03b2 signaling enhances IL-15-mediated human natural killer cell survival. Proc. Natl Acad. Sci. USA 119, e2114134119 (2022).","DOI":"10.1073\/pnas.2114134119"},{"key":"2198_CR316","doi-asserted-by":"publisher","first-page":"47ra63","DOI":"10.1126\/scitranslmed.3001001","volume":"2","author":"P Duffau","year":"2010","unstructured":"Duffau, P. et al. Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci. Transl. Med. 2, 47ra63 (2010).","journal-title":"Sci. Transl. Med."},{"key":"2198_CR317","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1111\/jth.15750","volume":"20","author":"AP Stone","year":"2022","unstructured":"Stone, A. P., Nikols, E., Freire, D. & Machlus, K. R. The pathobiology of platelet and megakaryocyte extracellular vesicles: a (c)lot has changed. J. Thromb. Haemost. 20, 1550\u20131558 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR318","doi-asserted-by":"crossref","unstructured":"Ma, Q. L. et al. Reshaping the inflammatory environment in rheumatoid arthritis joints by targeting delivery of berberine with platelet-derived extracellular vesicles. Adv. Nanobiomed. Res. 1, 2100071 (2021).","DOI":"10.1002\/anbr.202100115"},{"key":"2198_CR319","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/jim-2019-001195","volume":"68","author":"EWJ Kerris","year":"2020","unstructured":"Kerris, E. W. J., Hoptay, C., Calderon, T. & Freishtat, R. J. Platelets and platelet extracellular vesicles in hemostasis and sepsis. J. Invest. Med. 68, 813\u2013820 (2020).","journal-title":"J. Invest. Med."},{"key":"2198_CR320","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.3389\/fimmu.2018.02388","volume":"9","author":"OJ Arntz","year":"2018","unstructured":"Arntz, O. J. et al. Rheumatoid arthritis patients with circulating extracellular vesicles positive for IgM rheumatoid factor have higher disease activity. Front. Immunol. 9, 2388 (2018).","journal-title":"Front. Immunol."},{"key":"2198_CR321","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/ATVBAHA.120.314644","volume":"41","author":"F Puhm","year":"2021","unstructured":"Puhm, F., Boilard, E. & Machlus, K. R. Platelet extracellular vesicles: beyond the blood. Arterioscler. Thromb. Vasc. Biol. 41, 87\u201396 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR322","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1182\/bloodadvances.2020001758","volume":"4","author":"SL French","year":"2020","unstructured":"French, S. L. et al. Platelet-derived extracellular vesicles infiltrate and modify the bone marrow during inflammation. Blood Adv. 4, 3011\u20133023 (2020).","journal-title":"Blood Adv."},{"key":"2198_CR323","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J. D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785\u2013797 (2010).","journal-title":"Nat. Immunol."},{"key":"2198_CR324","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20041497","volume":"201","author":"I Del Conde","year":"2005","unstructured":"Del Conde, I. et al. Platelet activation leads to activation and propagation of the complement system. J. Exp. Med. 201, 871\u2013879 (2005).","journal-title":"J. Exp. Med."},{"key":"2198_CR325","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molimm.2015.03.244","volume":"67","author":"C Speth","year":"2015","unstructured":"Speth, C. et al. Complement and platelets: mutual interference in the immune network. Mol. Immunol. 67, 108\u2013118 (2015).","journal-title":"Mol. Immunol."},{"key":"2198_CR326","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1020712","volume":"13","author":"A Landsem","year":"2022","unstructured":"Landsem, A. et al. Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood. Front. Immunol. 13, 1020712 (2022).","journal-title":"Front. Immunol."},{"key":"2198_CR327","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25019-1","volume":"8","author":"JL Sylman","year":"2018","unstructured":"Sylman, J. L. et al. A temporal examination of platelet counts as a predictor of prognosis in lung, prostate, and colon cancer patients. Sci. Rep. 8, 6564 (2018).","journal-title":"Sci. Rep."},{"key":"2198_CR328","first-page":"785","volume":"38","author":"M Koupenova","year":"2017","unstructured":"Koupenova, M., Kehrel, B. E., Corkrey, H. A. & Freedman, J. E. Thrombosis and platelets: an update. Eur. Heart J. 38, 785\u2013791 (2017).","journal-title":"Eur. Heart J."},{"key":"2198_CR329","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101871","volume":"40","author":"D Trivanovi\u0107","year":"2024","unstructured":"Trivanovi\u0107, D. et al. Revealing profile of cancer-educated platelets and their factors to foster immunotherapy development. Transl. Oncol. 40, 101871 (2024).","journal-title":"Transl. Oncol."},{"key":"2198_CR330","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01342-w","volume":"28","author":"L Zhou","year":"2023","unstructured":"Zhou, L. et al. The critical role of platelet in cancer progression and metastasis. Eur. J. Med. Res. 28, 385 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"2198_CR331","doi-asserted-by":"publisher","first-page":"e2141633","DOI":"10.1001\/jamanetworkopen.2021.41633","volume":"5","author":"V Giannakeas","year":"2022","unstructured":"Giannakeas, V. et al. Analysis of platelet count and new cancer diagnosis over a 10-year period. JAMA Netw. Open 5, e2141633 (2022).","journal-title":"JAMA Netw. Open"},{"key":"2198_CR332","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.939089","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Emerging roles of platelets in cancer biology and their potential as therapeutic targets. Front. Oncol. 12, 939089 (2022).","journal-title":"Front. Oncol."},{"key":"2198_CR333","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1121401","volume":"13","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Platelets in the tumor microenvironment and their biological effects on cancer hallmarks. Front. Oncol. 13, 1121401 (2023).","journal-title":"Front. Oncol."},{"key":"2198_CR334","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1182\/blood.2019003976","volume":"137","author":"HG Roweth","year":"2021","unstructured":"Roweth, H. G. & Battinelli, E. M. Lessons to learn from tumor-educated platelets. Blood 137, 3174\u20133180 (2021).","journal-title":"Blood"},{"key":"2198_CR335","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1752-8062.2010.00226.x","volume":"3","author":"DC Calverley","year":"2010","unstructured":"Calverley, D. C. et al. Significant downregulation of platelet gene expression in metastatic lung cancer. Clin. Transl. Sci. 3, 227\u2013232 (2010).","journal-title":"Clin. Transl. Sci."},{"key":"2198_CR336","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jprot.2018.02.011","volume":"177","author":"S Sabrkhany","year":"2018","unstructured":"Sabrkhany, S. et al. Exploration of the platelet proteome in patients with early-stage cancer. J. Proteom. 177, 65\u201374 (2018).","journal-title":"J. Proteom."},{"key":"2198_CR337","first-page":"1146","volume":"135","author":"E Mammadova-Bach","year":"2020","unstructured":"Mammadova-Bach, E. et al. Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3. Blood 135, 1146\u20131160 (2020).","journal-title":"Blood"},{"key":"2198_CR338","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.4045","volume":"35","author":"J Ichikawa","year":"2020","unstructured":"Ichikawa, J. et al. Role of platelet C-type lectin-like receptor 2 in promoting lung metastasis in osteosarcoma. J. Bone Min. Res. 35, 1738\u20131750 (2020).","journal-title":"J. Bone Min. Res."},{"key":"2198_CR339","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1182\/blood-2013-03-492447","volume":"123","author":"A Mitrugno","year":"2014","unstructured":"Mitrugno, A., Williams, D., Kerrigan, S. W. & Moran, N. A novel and essential role for Fc\u03b3RIIa in cancer cell-induced platelet activation. Blood 123, 249\u2013260 (2014).","journal-title":"Blood"},{"key":"2198_CR340","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1152\/physiol.00020.2016","volume":"32","author":"B Estevez","year":"2017","unstructured":"Estevez, B. & Du, X. New concepts and mechanisms of platelet activation signaling. Physiology 32, 162\u2013177 (2017).","journal-title":"Physiology"},{"key":"2198_CR341","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/jth.13181","volume":"14","author":"JE Geddings","year":"2016","unstructured":"Geddings, J. E. et al. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J. Thromb. Haemost. 14, 153\u2013166 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR342","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10456-012-9259-z","volume":"15","author":"JE Peterson","year":"2012","unstructured":"Peterson, J. E. et al. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis 15, 265\u2013273 (2012).","journal-title":"Angiogenesis"},{"key":"2198_CR343","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1161\/CIRCRESAHA.122.321861","volume":"132","author":"T Dudiki","year":"2023","unstructured":"Dudiki, T. et al. Mechanism of tumor-platelet communications in cancer. Circ. Res. 132, 1447\u20131461 (2023).","journal-title":"Circ. Res."},{"key":"2198_CR344","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1182\/blood-2010-08-304808","volume":"117","author":"W Feng","year":"2011","unstructured":"Feng, W. et al. A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing. Blood 117, 3893\u20133902 (2011).","journal-title":"Blood"},{"key":"2198_CR345","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.4252\/wjsc.v12.i11.1237","volume":"12","author":"G Mendoza-Almanza","year":"2020","unstructured":"Mendoza-Almanza, G. et al. Role of platelets and breast cancer stem cells in metastasis. World J. Stem Cells 12, 1237\u20131254 (2020).","journal-title":"World J. Stem Cells"},{"key":"2198_CR346","doi-asserted-by":"publisher","first-page":"9780","DOI":"10.1021\/acsnano.0c01687","volume":"14","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. Blockade of platelets using tumor-specific NO-releasing nanoparticles prevents tumor metastasis and reverses tumor immunosuppression. ACS Nano 14, 9780\u20139795 (2020).","journal-title":"ACS Nano"},{"key":"2198_CR347","doi-asserted-by":"publisher","first-page":"e0261633","DOI":"10.1371\/journal.pone.0261633","volume":"16","author":"JGT Wurtzel","year":"2021","unstructured":"Wurtzel, J. G. T. et al. Platelet microRNAs inhibit primary tumor growth via broad modulation of tumor cell mRNA expression in ectopic pancreatic cancer in mice. PLoS ONE 16, e0261633 (2021).","journal-title":"PLoS ONE"},{"key":"2198_CR348","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2019.108242","volume":"74","author":"V Gasperi","year":"2019","unstructured":"Gasperi, V. et al. Polyunsaturated fatty acids modulate the delivery of platelet microvesicle-derived microRNAs into human breast cancer cell lines. J. Nutr. Biochem. 74, 108242 (2019).","journal-title":"J. Nutr. Biochem."},{"key":"2198_CR349","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood-2016-11-751099","volume":"130","author":"JV Michael","year":"2017","unstructured":"Michael, J. V. et al. Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth. Blood 130, 567\u2013580 (2017).","journal-title":"Blood"},{"key":"2198_CR350","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1158\/1535-7163.MCT-21-0050","volume":"20","author":"S Miao","year":"2021","unstructured":"Miao, S., Zhang, Q., Chang, W. & Wang, J. New insights into platelet-enriched miRNAs: production, functions, roles in tumors, and potential targets for tumor diagnosis and treatment. Mol. Cancer Ther. 20, 1359\u20131366 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"2198_CR351","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10555-017-9674-0","volume":"36","author":"N Sol","year":"2017","unstructured":"Sol, N. & Wurdinger, T. Platelet RNA signatures for the detection of cancer. Cancer Metastasis Rev. 36, 263\u2013272 (2017).","journal-title":"Cancer Metastasis Rev."},{"key":"2198_CR352","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0464-x","volume":"17","author":"XX Zuo","year":"2019","unstructured":"Zuo, X. X. et al. Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin \u03b12\u03b21-contacting-mediated activation of Wnt-\u03b2-catenin pathway. Cell Commun. Signal 17, 142 (2019).","journal-title":"Cell Commun. Signal"},{"key":"2198_CR353","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1158\/1541-7786.MCR-23-0329","volume":"22","author":"V Veilleux","year":"2024","unstructured":"Veilleux, V., Pichaud, N., Boudreau, L. H. & Robichaud, G. A. Mitochondria transfer by platelet-derived microparticles regulates breast cancer bioenergetic states and malignant features. Mol. Cancer Res. 22, 268\u2013281 (2024).","journal-title":"Mol. Cancer Res."},{"key":"2198_CR354","first-page":"450","volume":"27","author":"XL Lou","year":"2015","unstructured":"Lou, X. L. et al. Interaction between circulating cancer cells and platelets: clinical implication. Chin. J. Cancer Res. 27, 450\u2013460 (2015).","journal-title":"Chin. J. Cancer Res."},{"key":"2198_CR355","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1080\/15384047.2015.1095411","volume":"16","author":"OM Ohana","year":"2015","unstructured":"Ohana, O. M. et al. Hodgkin lymphoma cell lines bind to platelets. Incubation with platelets induces CD15 and P-selectin dependent adhesion of the cell lines to Human Umbilical Vein Endothelial cells (HUVEC). Cancer Biol. Ther. 16, 1651\u20131659 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"2198_CR356","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12959-023-00463-w","volume":"21","author":"H Xin","year":"2023","unstructured":"Xin, H. et al. Structure, signal transduction, activation, and inhibition of integrin \u03b1IIb\u03b23. Thromb. J. 21, 18 (2023).","journal-title":"Thromb. J."},{"key":"2198_CR357","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.909767","volume":"12","author":"W Strasenburg","year":"2022","unstructured":"Strasenburg, W. et al. Tumor cell-induced platelet aggregation as an emerging therapeutic target for cancer therapy. Front. Oncol. 12, 909767 (2022).","journal-title":"Front. Oncol."},{"key":"2198_CR358","doi-asserted-by":"publisher","first-page":"106301","DOI":"10.1016\/j.phrs.2022.106301","volume":"182","author":"B Tesfamariam","year":"2022","unstructured":"Tesfamariam, B. & Wood, S. C. Targeting glycoprotein VI to disrupt platelet-mediated tumor cell extravasation. Pharm. Res. 182, 106301 (2022).","journal-title":"Pharm. Res."},{"key":"2198_CR359","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/jth.15543","volume":"20","author":"N Martins Castanheira","year":"2022","unstructured":"Martins Castanheira, N. et al. Uptake of platelets by cancer cells and recycling of the platelet protein CD42a. J. Thromb. Haemost. 20, 170\u2013181 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR360","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","volume":"41","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell 41, 272\u2013287.e279 (2023).","journal-title":"Cancer Cell"},{"key":"2198_CR361","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Platelet-derived PDGFB promotes recruitment of cancer-associated fibroblasts, deposition of extracellular matrix and Tgf\u03b2 signaling in the tumor microenvironment. Cancers 14, 1947 (2022).","DOI":"10.3390\/cancers14081947"},{"key":"2198_CR362","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76351-4","volume":"10","author":"AB Zaslavsky","year":"2020","unstructured":"Zaslavsky, A. B. et al. Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors. Sci. Rep. 10, 19296 (2020).","journal-title":"Sci. Rep."},{"key":"2198_CR363","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1038\/onc.2010.619","volume":"30","author":"TJ Standiford","year":"2011","unstructured":"Standiford, T. J. et al. TGF-\u03b2-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth. Oncogene 30, 2475\u20132484 (2011).","journal-title":"Oncogene"},{"key":"2198_CR364","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc8188","volume":"13","author":"MA Schneider","year":"2021","unstructured":"Schneider, M. A. et al. Attenuation of peripheral serotonin inhibits tumor growth and enhances immune checkpoint blockade therapy in murine tumor models. Sci. Transl. Med. 13, eabc8188 (2021).","journal-title":"Sci. Transl. Med."},{"key":"2198_CR365","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1073\/pnas.1612920114","volume":"114","author":"V Prima","year":"2017","unstructured":"Prima, V. et al. COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells. Proc. Natl Acad. Sci. USA 114, 1117\u20131122 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2198_CR366","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.2174\/0929867325666180417170218","volume":"26","author":"JJ Lopez","year":"2019","unstructured":"Lopez, J. J. et al. Flavonoids and platelet-derived thrombotic disorders. Curr. Med. Chem. 26, 7035\u20137047 (2019).","journal-title":"Curr. Med. Chem."},{"key":"2198_CR367","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1007\/s12325-020-01453-4","volume":"37","author":"AD Kaye","year":"2020","unstructured":"Kaye, A. D. et al. Platelet dysfunction diseases and conditions: clinical implications and considerations. Adv. Ther. 37, 3707\u20133722 (2020).","journal-title":"Adv. Ther."},{"key":"2198_CR368","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/joim.13794","volume":"296","author":"N Li","year":"2024","unstructured":"Li, N. Platelets as an inter-player between hyperlipidaemia and atherosclerosis. J. Intern. Med. 296, 39\u201352 (2024).","journal-title":"J. Intern. Med."},{"key":"2198_CR369","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1055\/a-2235-7485","volume":"124","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Platelet-derived TGF-\u03b21 promotes deep vein thrombosis. Thromb. Haemost. 124, 641\u2013648 (2024).","journal-title":"Thromb. Haemost."},{"key":"2198_CR370","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/pin.13305","volume":"73","author":"A Yamashita","year":"2023","unstructured":"Yamashita, A. & Asada, Y. Underlying mechanisms of thrombus formation\/growth in atherothrombosis and deep vein thrombosis. Pathol. Int. 73, 65\u201380 (2023).","journal-title":"Pathol. Int."},{"key":"2198_CR371","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby, P. The changing landscape of atherosclerosis. Nature 592, 524\u2013533 (2021).","journal-title":"Nature"},{"key":"2198_CR372","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-117","volume":"11","author":"J Frosteg\u00e5rd","year":"2013","unstructured":"Frosteg\u00e5rd, J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 11, 117 (2013).","journal-title":"BMC Med."},{"key":"2198_CR373","doi-asserted-by":"crossref","unstructured":"G\u0105secka, A., Rogula, S., Szarpak, \u0141. & Filipiak, K. J. LDL-cholesterol and platelets: insights into their interactions in atherosclerosis. Life 11, 39 (2021).","DOI":"10.3390\/life11010039"},{"key":"2198_CR374","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2020.05.018","volume":"307","author":"H Nording","year":"2020","unstructured":"Nording, H., Baron, L. & Langer, H. F. Platelets as therapeutic targets to prevent atherosclerosis. Atherosclerosis 307, 97\u2013108 (2020).","journal-title":"Atherosclerosis"},{"key":"2198_CR375","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.114.002765","volume":"8","author":"CY Shim","year":"2015","unstructured":"Shim, C. Y. et al. Molecular imaging of platelet-endothelial interactions and endothelial von Willebrand factor in early and mid-stage atherosclerosis. Circ. Cardiovasc. Imaging 8, e002765 (2015).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"2198_CR376","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1160\/TH14-11-0911","volume":"114","author":"S Meyer Dos Santos","year":"2015","unstructured":"Meyer Dos Santos, S. et al. Platelets from flowing blood attach to the inflammatory chemokine CXCL16 expressed in the endothelium of the human vessel wall. Thromb. Haemost. 114, 297\u2013312 (2015).","journal-title":"Thromb. Haemost."},{"key":"2198_CR377","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/eurheartj\/ehab631","volume":"43","author":"S Momi","year":"2022","unstructured":"Momi, S. et al. Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis. Eur. Heart J. 43, 504\u2013514 (2022).","journal-title":"Eur. Heart J."},{"key":"2198_CR378","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1161\/01.CIR.101.19.2290","volume":"101","author":"ZM Dong","year":"2000","unstructured":"Dong, Z. M., Brown, A. A. & Wagner, D. D. Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation 101, 2290\u20132295 (2000).","journal-title":"Circulation"},{"key":"2198_CR379","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1182\/blood-2002-07-2209","volume":"101","author":"PC Burger","year":"2003","unstructured":"Burger, P. C. & Wagner, D. D. Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101, 2661\u20132666 (2003).","journal-title":"Blood"},{"key":"2198_CR380","doi-asserted-by":"crossref","unstructured":"Puteri, M. U., Azmi, N. U., Kato, M. & Saputri, F. C. PCSK9 promotes cardiovascular diseases: recent evidence about its association with platelet activation-induced myocardial infarction. Life 12, 190 (2022).","DOI":"10.3390\/life12020190"},{"key":"2198_CR381","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1182\/blood-2014-06-580597","volume":"125","author":"D Cherpokova","year":"2015","unstructured":"Cherpokova, D. et al. SLAP\/SLAP2 prevent excessive platelet (hem)ITAM signaling in thrombosis and ischemic stroke in mice. Blood 125, 185\u2013194 (2015).","journal-title":"Blood"},{"key":"2198_CR382","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","volume":"143","author":"Z Qi","year":"2021","unstructured":"Qi, Z. et al. PCSK9 (proprotein convertase subtilisin\/kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36. Circulation 143, 45\u201361 (2021).","journal-title":"Circulation"},{"key":"2198_CR383","doi-asserted-by":"crossref","unstructured":"Cammisotto, V. et al. PCSK9 regulates Nox2-mediated platelet activation via CD36 receptor in patients with atrial fibrillation. Antioxidants 9, 296 (2020).","DOI":"10.3390\/antiox9040296"},{"key":"2198_CR384","doi-asserted-by":"crossref","unstructured":"Huseynov, A. et al. Novel aspects targeting platelets in atherosclerotic cardiovascular disease\u2014a translational perspective. Int. J. Mol. Sci. 24, 6280 (2023).","DOI":"10.3390\/ijms24076280"},{"key":"2198_CR385","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.06.008","volume":"122","author":"B Linke","year":"2019","unstructured":"Linke, B. et al. CXCL16\/CXCR6-mediated adhesion of human peripheral blood mononuclear cells to inflamed endothelium. Cytokine 122, 154081 (2019).","journal-title":"Cytokine"},{"key":"2198_CR386","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1002\/jcb.27844","volume":"120","author":"X Liang","year":"2019","unstructured":"Liang, X. et al. Platelet-neutrophil interaction aggravates vascular inflammation and promotes the progression of atherosclerosis by activating the TLR4\/NF-\u03baB pathway. J. Cell Biochem. 120, 5612\u20135619 (2019).","journal-title":"J. Cell Biochem."},{"key":"2198_CR387","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2014.08.041","volume":"237","author":"R Carnevale","year":"2014","unstructured":"Carnevale, R. et al. LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism. Atherosclerosis 237, 108\u2013116 (2014).","journal-title":"Atherosclerosis"},{"key":"2198_CR388","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101569","volume":"34","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. p47phox deficiency impairs platelet function and protects mice against arterial and venous thrombosis. Redox Biol. 34, 101569 (2020).","journal-title":"Redox Biol."},{"key":"2198_CR389","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2174\/0929867325666180508100950","volume":"26","author":"AJ Kattoor","year":"2019","unstructured":"Kattoor, A. J., Kanuri, S. H. & Mehta, J. L. Role of Ox-LDL and LOX-1 in atherogenesis. Curr. Med. Chem. 26, 1693\u20131700 (2019).","journal-title":"Curr. Med. Chem."},{"key":"2198_CR390","doi-asserted-by":"crossref","unstructured":"Hong, H. J., Nam, G. S. & Nam, K. S. Daidzein inhibits human platelet activation by downregulating thromboxane A2 production and granule release, regardless of COX-1 activity. Int. J. Mol. Sci. 24, 11985 (2023).","DOI":"10.3390\/ijms241511985"},{"key":"2198_CR391","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1039\/D2FO03958C","volume":"14","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. Sulforaphane attenuates glycoprotein VI-mediated platelet mitochondrial dysfunction through up-regulating the cAMP\/PKA signaling pathway in vitro and in vivo. Food Funct. 14, 3613\u20133629 (2023).","journal-title":"Food Funct."},{"key":"2198_CR392","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2024.113866","volume":"237","author":"A Wang","year":"2024","unstructured":"Wang, A. et al. Inhibition of platelet adhesion to exposed subendothelial collagen by steric hindrance with blocking peptide nanoparticles. Colloids Surf. B Biointerfaces 237, 113866 (2024).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"2198_CR393","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s12013-015-0553-4","volume":"72","author":"L Lu","year":"2015","unstructured":"Lu, L. et al. Myocardial infarction: symptoms and treatments. Cell Biochem. Biophys. 72, 865\u2013867 (2015).","journal-title":"Cell Biochem. Biophys."},{"key":"2198_CR394","doi-asserted-by":"crossref","unstructured":"Zhang, W. et al. Hypoxic mitophagy regulates mitochondrial quality and platelet activation and determines severity of I\/R heart injury. eLife 5, e21407 (2016).","DOI":"10.7554\/eLife.21407"},{"key":"2198_CR395","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.thromres.2021.11.019","volume":"209","author":"F Barill\u00e0","year":"2022","unstructured":"Barill\u00e0, F. et al. Toll-like receptor 4 activation in platelets from myocardial infarction patients. Thromb. Res. 209, 33\u201340 (2022).","journal-title":"Thromb. Res."},{"key":"2198_CR396","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/ATVBAHA.122.318161","volume":"43","author":"S Miao","year":"2023","unstructured":"Miao, S. et al. Platelet internalization mediates ferroptosis in myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 43, 218\u2013230 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR397","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1161\/ATVBAHA.123.319767","volume":"43","author":"SK Lee","year":"2023","unstructured":"Lee, S. K. et al. PAR4 inhibition reduces coronary artery atherosclerosis and myocardial fibrosis in SR-B1\/LDLR double knockout mice. Arterioscler. Thromb. Vasc. Biol. 43, 2165\u20132178 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR398","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1538-7836.2011.04361.x","volume":"9","author":"B Nieswandt","year":"2011","unstructured":"Nieswandt, B., Pleines, I. & Bender, M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J. Thromb. Haemost. 9, 92\u2013104 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR399","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/CIRCRESAHA.120.316655","volume":"127","author":"MK Schuhmann","year":"2020","unstructured":"Schuhmann, M. K. et al. CD84 links T cell and platelet activity in cerebral thrombo-inflammation in acute stroke. Circ. Res. 127, 1023\u20131035 (2020).","journal-title":"Circ. Res."},{"key":"2198_CR400","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1182\/blood.2019002124","volume":"135","author":"F Denorme","year":"2020","unstructured":"Denorme, F. et al. Platelet necrosis mediates ischemic stroke outcome in mice. Blood 135, 429\u2013440 (2020).","journal-title":"Blood"},{"key":"2198_CR401","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1124\/pr.117.014530","volume":"70","author":"J Yeung","year":"2018","unstructured":"Yeung, J., Li, W. J. & Holinstat, M. Platelet signaling and disease: targeted therapy for thrombosis and other related diseases. Pharm. Rev. 70, 526\u2013548 (2018).","journal-title":"Pharm. Rev."},{"key":"2198_CR402","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1515\/cclm-2018-0909","volume":"57","author":"J Zhou","year":"2019","unstructured":"Zhou, J. et al. Circulating platelet-neutrophil aggregates as risk factor for deep venous thrombosis. Clin. Chem. Lab. Med. 57, 707\u2013715 (2019).","journal-title":"Clin. Chem. Lab. Med."},{"key":"2198_CR403","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1055\/s-0038-1673614","volume":"118","author":"Y Feng","year":"2018","unstructured":"Feng, Y. et al. IL-9 promotes the development of deep venous thrombosis by facilitating platelet function. Thromb. Haemost. 118, 1885\u20131894 (2018).","journal-title":"Thromb. Haemost."},{"key":"2198_CR404","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1182\/blood-2016-04-710632","volume":"128","author":"K Stark","year":"2016","unstructured":"Stark, K. et al. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood 128, 2435\u20132449 (2016).","journal-title":"Blood"},{"key":"2198_CR405","doi-asserted-by":"crossref","unstructured":"Wang, X. et al. Platelet (hem)ITAM signaling mediated cancer-associated venous thrombosis. Blood 132, 2509 (2018).","DOI":"10.1182\/blood-2018-99-116220"},{"key":"2198_CR406","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1016\/j.jtha.2023.07.005","volume":"21","author":"T Shirai","year":"2023","unstructured":"Shirai, T. et al. Cancer-associated fibroblasts promote venous thrombosis through podoplanin\/CLEC-2 interaction in podoplanin-negative lung cancer mouse model. J. Thromb. Haemost. 21, 3153\u20133165 (2023).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR407","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1182\/blood-2015-10-672964","volume":"128","author":"J Yang","year":"2016","unstructured":"Yang, J. et al. mTORC1 promotes aging-related venous thrombosis in mice via elevation of platelet volume and activation. Blood 128, 615\u2013624 (2016).","journal-title":"Blood"},{"key":"2198_CR408","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17474086.2017.1271319","volume":"10","author":"M Franchini","year":"2017","unstructured":"Franchini, M., Veneri, D. & Lippi, G. Thrombocytopenia and infections. Expert Rev. Hematol. 10, 99\u2013106 (2017).","journal-title":"Expert Rev. Hematol."},{"key":"2198_CR409","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/bjh.17172","volume":"192","author":"K Adelborg","year":"2021","unstructured":"Adelborg, K., Larsen, J. B. & Hvas, A. M. Disseminated intravascular coagulation: epidemiology, biomarkers, and management. Br. J. Haematol. 192, 803\u2013818 (2021).","journal-title":"Br. J. Haematol."},{"key":"2198_CR410","doi-asserted-by":"publisher","DOI":"10.1038\/srep23653","volume":"6","author":"D Liu","year":"2016","unstructured":"Liu, D. et al. Suppressive effect of exogenous carbon monoxide on endotoxin-stimulated platelet over-activation via the glycoprotein-mediated PI3K-Akt-GSK3\u03b2 pathway. Sci. Rep. 6, 23653 (2016).","journal-title":"Sci. Rep."},{"key":"2198_CR411","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cellimm.2018.04.002","volume":"328","author":"G Feng","year":"2018","unstructured":"Feng, G. et al. LPS enhances platelets aggregation via TLR4, which is related to mitochondria damage caused by intracellular ROS, but not extracellular ROS. Cell Immunol. 328, 86\u201392 (2018).","journal-title":"Cell Immunol."},{"key":"2198_CR412","doi-asserted-by":"publisher","DOI":"10.1186\/cc9337","volume":"14","author":"F Sj\u00f6vall","year":"2010","unstructured":"Sj\u00f6vall, F. et al. Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis. Crit. Care 14, R214 (2010).","journal-title":"Crit. Care"},{"key":"2198_CR413","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0762-7","volume":"19","author":"A Protti","year":"2015","unstructured":"Protti, A. et al. Platelet mitochondrial dysfunction in critically ill patients: comparison between sepsis and cardiogenic shock. Crit. Care 19, 39 (2015).","journal-title":"Crit. Care"},{"key":"2198_CR414","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/j.1538-7836.2010.03875.x","volume":"8","author":"SP Watson","year":"2010","unstructured":"Watson, S. P., Herbert, J. M. & Pollitt, A. Y. GPVI and CLEC-2 in hemostasis and vascular integrity. J. Thromb. Haemost. 8, 1456\u20131467 (2010).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR415","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1182\/blood.2020009774","volume":"137","author":"Weiss","year":"2021","unstructured":"Weiss et al. Acquired platelet GPVI receptor dysfunction in critically ill patients with sepsis. Blood 137, 3105\u20133115 (2021).","journal-title":"Blood"},{"key":"2198_CR416","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1111\/jcmm.16382","volume":"25","author":"DF Xu","year":"2021","unstructured":"Xu, D. F. et al. Elevated angiotensin II induces platelet apoptosis through promoting oxidative stress in an AT1R-dependent manner during sepsis. J. Cell Mol. Med. 25, 4124\u20134135 (2021).","journal-title":"J. Cell Mol. Med."},{"key":"2198_CR417","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.4049\/jimmunol.2200222","volume":"210","author":"CM Chang","year":"2023","unstructured":"Chang, C. M. et al. Soluble TREM-like Transcript-1 acts as a damage-associated molecular pattern through the TLR4\/MD2 pathway contributing to immune dysregulation during sepsis. J. Immunol. 210, 1351\u20131362 (2023).","journal-title":"J. Immunol."},{"key":"2198_CR418","doi-asserted-by":"crossref","unstructured":"Sagar, R. C., Ajjan, R. A. & Naseem, K. M. Non-traditional pathways for platelet pathophysiology in diabetes: implications for future therapeutic targets. Int. J. Mol. Sci. 23, 4973 (2022).","DOI":"10.3390\/ijms23094973"},{"key":"2198_CR419","doi-asserted-by":"publisher","first-page":"147916412094211","DOI":"10.1177\/1479164120942119","volume":"17","author":"S Shen","year":"2020","unstructured":"Shen, S., Wang, F., Fernandez, A. & Hu, W. Role of platelet-derived growth factor in type II diabetes mellitus and its complications. Diab. Vasc. Dis. Res. 17, 1479164120942119 (2020).","journal-title":"Diab. Vasc. Dis. Res."},{"key":"2198_CR420","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson, T. R., Acs, A., Ludwig, C. & Panton, U. H. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc. Diabetol. 17, 83 (2018).","journal-title":"Cardiovasc. Diabetol."},{"key":"2198_CR421","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ccl.2004.06.009","volume":"22","author":"BE Sobel","year":"2004","unstructured":"Sobel, B. E. & Schneider, D. J. Platelet function, coagulopathy, and impaired fibrinolysis in diabetes. Cardiol. Clin. 22, 511\u2013526 (2004).","journal-title":"Cardiol. Clin."},{"key":"2198_CR422","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00059-016-4414-8","volume":"41","author":"RJ King","year":"2016","unstructured":"King, R. J. & Grant, P. J. Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic. Herz 41, 184\u2013192 (2016).","journal-title":"Herz"},{"key":"2198_CR423","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.amjcard.2003.08.033","volume":"92","author":"FK Keating","year":"2003","unstructured":"Keating, F. K., Sobel, B. E. & Schneider, D. J. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus. Am. J. Cardiol. 92, 1362\u20131365 (2003).","journal-title":"Am. J. Cardiol."},{"key":"2198_CR424","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s001250051598","volume":"44","author":"R Assert","year":"2001","unstructured":"Assert, R. et al. Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro. Diabetologia 44, 188\u2013195 (2001).","journal-title":"Diabetologia"},{"key":"2198_CR425","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2337\/dc08-1942","volume":"32","author":"V Randriamboavonjy","year":"2009","unstructured":"Randriamboavonjy, V. & Fleming, I. Insulin, insulin resistance, and platelet signaling in diabetes. Diab. Care 32, 528\u2013530 (2009).","journal-title":"Diab. Care"},{"key":"2198_CR426","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1182\/blood.V57.5.956.956","volume":"57","author":"JW Akkerman","year":"1981","unstructured":"Akkerman, J. W. & Holmsen, H. Interrelationships among platelet responses: studies on the burst in proton liberation, lactate production, and oxygen uptake during platelet aggregation and Ca2+ secretion. Blood 57, 956\u2013966 (1981).","journal-title":"Blood"},{"key":"2198_CR427","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.lfs.2016.02.030","volume":"148","author":"K Siewiera","year":"2016","unstructured":"Siewiera, K. et al. Higher mitochondrial potential and elevated mitochondrial respiration are associated with excessive activation of blood platelets in diabetic rats. Life Sci. 148, 293\u2013304 (2016).","journal-title":"Life Sci."},{"key":"2198_CR428","doi-asserted-by":"crossref","unstructured":"Siewiera, K. et al. Potential role of mitochondria as modulators of blood platelet activation and reactivity in diabetes and effect of metformin on blood platelet bioenergetics and platelet activation. Int. J. Mol. Sci. 23, 3666 (2022).","DOI":"10.3390\/ijms23073666"},{"key":"2198_CR429","doi-asserted-by":"crossref","unstructured":"Lee, S. H., Du, J., Hwa, J. & Kim, W. H. Parkin coordinates platelet stress response in diabetes mellitus: a big role in a small cell. Int. J. Mol. Sci. 21, 5869 (2020).","DOI":"10.3390\/ijms21165869"},{"key":"2198_CR430","doi-asserted-by":"publisher","DOI":"10.1038\/srep36222","volume":"6","author":"G Xin","year":"2016","unstructured":"Xin, G. et al. Metformin uniquely prevents thrombosis by inhibiting platelet activation and mtDNA release. Sci. Rep. 6, 36222 (2016).","journal-title":"Sci. Rep."},{"key":"2198_CR431","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/cbf.3120","volume":"33","author":"AA Farooqi","year":"2015","unstructured":"Farooqi, A. A. & Siddik, Z. H. Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape. Cell Biochem. Funct. 33, 257\u2013265 (2015).","journal-title":"Cell Biochem. Funct."},{"key":"2198_CR432","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","volume":"24","author":"A Ceriello","year":"2004","unstructured":"Ceriello, A. & Motz, E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24, 816\u2013823 (2004).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR433","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bbrc.2019.06.048","volume":"516","author":"Z Shan","year":"2019","unstructured":"Shan, Z., Xu, C., Wang, W. & Li, W. Enhanced PDGF signaling in gestational diabetes mellitus is involved in pancreatic \u03b2-cell dysfunction. Biochem. Biophys. Res. Commun. 516, 402\u2013407 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2198_CR434","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.2337\/db17-1539","volume":"67","author":"A Abderrahmani","year":"2018","unstructured":"Abderrahmani, A. et al. Increased hepatic PDGF-AA signaling mediates liver insulin resistance in obesity-associated type 2 diabetes. Diabetes 67, 1310\u20131321 (2018).","journal-title":"Diabetes"},{"key":"2198_CR435","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1055\/s-0039-1701011","volume":"120","author":"W Sumaya","year":"2020","unstructured":"Sumaya, W. et al. Impaired fibrinolysis predicts adverse outcome in acute coronary syndrome patients with diabetes: a PLATO sub-study. Thromb. Haemost. 120, 412\u2013422 (2020).","journal-title":"Thromb. Haemost."},{"key":"2198_CR436","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103146","volume":"72","author":"XB Wang","year":"2024","unstructured":"Wang, X. B. et al. Platelet bioenergetic profiling uncovers a metabolic pattern of high dependency on mitochondrial fatty acid oxidation in type 2 diabetic patients who developed in-stent restenosis. Redox Biol. 72, 103146 (2024).","journal-title":"Redox Biol."},{"key":"2198_CR437","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1570161115666170126130309","volume":"15","author":"N Cortez-Espinosa","year":"2017","unstructured":"Cortez-Espinosa, N. et al. Platelets and platelet-derived microvesicles as immune effectors in type 2 diabetes. Curr. Vasc. Pharm. 15, 207\u2013217 (2017).","journal-title":"Curr. Vasc. Pharm."},{"key":"2198_CR438","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41577-023-00834-4","volume":"23","author":"M Scherlinger","year":"2023","unstructured":"Scherlinger, M. et al. The role of platelets in immune-mediated inflammatory diseases. Nat. Rev. Immunol. 23, 495\u2013510 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2198_CR439","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1126\/science.1181928","volume":"327","author":"E Boilard","year":"2010","unstructured":"Boilard, E. et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327, 580\u2013583 (2010).","journal-title":"Science"},{"key":"2198_CR440","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102355","volume":"107","author":"IA Andrianova","year":"2020","unstructured":"Andrianova, I. A. et al. In systemic lupus erythematosus anti-dsDNA antibodies can promote thrombosis through direct platelet activation. J. Autoimmun. 107, 102355 (2020).","journal-title":"J. Autoimmun."},{"key":"2198_CR441","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40900-3","volume":"9","author":"Y Becker","year":"2019","unstructured":"Becker, Y. et al. Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations. Sci. Rep. 9, 4530 (2019).","journal-title":"Sci. Rep."},{"key":"2198_CR442","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11926-022-01063-9","volume":"24","author":"PM Chen","year":"2022","unstructured":"Chen, P. M. & Tsokos, G. C. Mitochondria in the pathogenesis of systemic lupus erythematosus. Curr. Rheumatol. Rep. 24, 88\u201395 (2022).","journal-title":"Curr. Rheumatol. Rep."},{"key":"2198_CR443","doi-asserted-by":"crossref","unstructured":"Melki, I. et al. Platelets release mitochondrial antigens in systemic lupus erythematosus. Sci. Transl. Med. 13, eaav5928 (2021).","DOI":"10.1126\/scitranslmed.aav5928"},{"key":"2198_CR444","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun, L. et al. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786\u2013791 (2013).","journal-title":"Science"},{"key":"2198_CR445","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109746","volume":"255","author":"D Michailidou","year":"2023","unstructured":"Michailidou, D. et al. Mitochondrial-mediated inflammation and platelet activation in giant cell arteritis. Clin. Immunol. 255, 109746 (2023).","journal-title":"Clin. Immunol."},{"key":"2198_CR446","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.4049\/jimmunol.176.11.6991","volume":"176","author":"MP Kuligowski","year":"2006","unstructured":"Kuligowski, M. P., Kitching, A. R. & Hickey, M. J. Leukocyte recruitment to the inflamed glomerulus: a critical role for platelet-derived P-selectin in the absence of rolling. J. Immunol. 176, 6991\u20136999 (2006).","journal-title":"J. Immunol."},{"key":"2198_CR447","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13075-017-1238-8","volume":"19","author":"Y Yuan","year":"2017","unstructured":"Yuan, Y. et al. Excessive activation of the TLR9\/TGF-\u03b21\/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus. Arthritis Res. Ther. 19, 70 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"2198_CR448","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","volume":"7","author":"M Zhao","year":"2022","unstructured":"Zhao, M. et al. Targeting fibrosis, mechanisms and cilinical trials. Signal Transduct. Target. Ther. 7, 206 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2198_CR449","doi-asserted-by":"publisher","first-page":"107057","DOI":"10.1016\/j.vascn.2021.107057","volume":"109","author":"R Carrington","year":"2021","unstructured":"Carrington, R. et al. A novel murine model of pulmonary fibrosis: the role of platelets in chronic changes induced by bleomycin. J. Pharm. Toxicol. Methods 109, 107057 (2021).","journal-title":"J. Pharm. Toxicol. Methods"},{"key":"2198_CR450","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molimm.2020.01.017","volume":"120","author":"T Zhan","year":"2020","unstructured":"Zhan, T. et al. Cangrelor alleviates bleomycin-induced pulmonary fibrosis by inhibiting platelet activation in mice. Mol. Immunol. 120, 83\u201392 (2020).","journal-title":"Mol. Immunol."},{"key":"2198_CR451","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120538","volume":"269","author":"H Kabra","year":"2021","unstructured":"Kabra, H. et al. Localized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis. Biomaterials 269, 120538 (2021).","journal-title":"Biomaterials"},{"key":"2198_CR452","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308505","volume":"11","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Single-cell spatial transcriptomics unveils platelet-fueled cycling macrophages for kidney fibrosis. Adv. Sci. 11, e2308505 (2024).","journal-title":"Adv. Sci."},{"key":"2198_CR453","doi-asserted-by":"publisher","first-page":"H1719","DOI":"10.1152\/ajpheart.00130.2013","volume":"304","author":"T Zhao","year":"2013","unstructured":"Zhao, T. et al. Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 304, H1719\u20131726 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2198_CR454","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1182\/blood-2011-09-377648","volume":"119","author":"A Meyer","year":"2012","unstructured":"Meyer, A. et al. Platelet TGF-\u03b21 contributions to plasma TGF-\u03b21, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload. Blood 119, 1064\u20131074 (2012).","journal-title":"Blood"},{"key":"2198_CR455","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.yjmcc.2008.12.019","volume":"46","author":"S Yabanoglu","year":"2009","unstructured":"Yabanoglu, S. et al. Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J. Mol. Cell Cardiol. 46, 518\u2013525 (2009).","journal-title":"J. Mol. Cell Cardiol."},{"key":"2198_CR456","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.3892\/mmr.2016.5186","volume":"13","author":"GZ Liu","year":"2016","unstructured":"Liu, G. Z. et al. P-selectin increases angiotensin II-induced cardiac inflammation and fibrosis via platelet activation. Mol. Med Rep. 13, 5021\u20135028 (2016).","journal-title":"Mol. Med Rep."},{"key":"2198_CR457","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1055\/s-0039-1695770","volume":"119","author":"AM Lima","year":"2019","unstructured":"Lima, A. M. et al. From patients to platelets and back again: pharmacological approaches to glycoprotein VI, a thrilling antithrombotic target with minor bleeding risks. Thromb. Haemost. 119, 1720\u20131739 (2019).","journal-title":"Thromb. Haemost."},{"key":"2198_CR458","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1161\/ATVBAHA.120.314301","volume":"40","author":"MU Ahmed","year":"2020","unstructured":"Ahmed, M. U. et al. Pharmacological blockade of glycoprotein VI promotes thrombus disaggregation in the absence of thrombin. Arterioscler. Thromb. Vasc. Biol. 40, 2127\u20132142 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR459","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1161\/ATVBAHA.118.312314","volume":"39","author":"C Voors-Pette","year":"2019","unstructured":"Voors-Pette, C. et al. Safety and tolerability, pharmacokinetics, and pharmacodynamics of ACT017, an antiplatelet GPVI (glycoprotein VI) fab. Arterioscler. Thromb. Vasc. Biol. 39, 956\u2013964 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR460","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1001\/jamacardio.2021.0475","volume":"6","author":"K Mayer","year":"2021","unstructured":"Mayer, K. et al. Efficacy and safety of Revacept, a novel lesion-directed competitive antagonist to platelet glycoprotein VI, in patients undergoing elective percutaneous coronary intervention for stable ischemic heart disease: the randomized, double-blind, placebo-controlled ISAR-PLASTER phase 2 trial. JAMA Cardiol. 6, 753\u2013761 (2021).","journal-title":"JAMA Cardiol."},{"key":"2198_CR461","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1161\/STROKEAHA.121.037006","volume":"53","author":"T Uphaus","year":"2022","unstructured":"Uphaus, T. et al. Revacept, an inhibitor of platelet adhesion in symptomatic carotid stenosis: a multicenter randomized phase II trial. Stroke 53, 2718\u20132729 (2022).","journal-title":"Stroke"},{"key":"2198_CR462","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2021.01.016","volume":"184","author":"EF Sanchez","year":"2021","unstructured":"Sanchez, E. F. et al. A fibrinolytic snake venom metalloproteinase, mutalysin-II, with antiplatelet activity and targeting capability toward glycoprotein GPIb\u03b1 and glycoprotein GPVI. Biochimie 184, 1\u20137 (2021).","journal-title":"Biochimie"},{"key":"2198_CR463","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114315","volume":"183","author":"G Pan","year":"2021","unstructured":"Pan, G. et al. GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI. Biochem. Pharm. 183, 114315 (2021).","journal-title":"Biochem. Pharm."},{"key":"2198_CR464","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.thromres.2007.03.011","volume":"120","author":"ZM Ruggeri","year":"2007","unstructured":"Ruggeri, Z. M. The role of von Willebrand factor in thrombus formation. Thromb. Res. 120, S5\u2013S9 (2007).","journal-title":"Thromb. Res."},{"key":"2198_CR465","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1160\/TH13-06-0490","volume":"111","author":"X Lei","year":"2014","unstructured":"Lei, X. et al. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis. Thromb. Haemost. 111, 279\u2013289 (2014).","journal-title":"Thromb. Haemost."},{"key":"2198_CR466","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91165-8","volume":"11","author":"BX Li","year":"2021","unstructured":"Li, B. X. et al. In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIb\u03b1. Sci. Rep. 11, 11663 (2021).","journal-title":"Sci. Rep."},{"key":"2198_CR467","doi-asserted-by":"publisher","first-page":"642761","DOI":"10.3389\/fonc.2021.642761","volume":"11","author":"H Fabricius","year":"2021","unstructured":"Fabricius, H., Starzonek, S. & Lange, T. The role of platelet cell surface P-selectin for the direct platelet-tumor cell contact during metastasis formation in human tumors. Front. Oncol. 11, 642761 (2021).","journal-title":"Front. Oncol."},{"key":"2198_CR468","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","volume":"376","author":"KI Ataga","year":"2017","unstructured":"Ataga, K. I. et al. Crizanlizumab for the prevention of pain crises in sickle cell disease. N. Engl. J. Med. 376, 429\u2013439 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2198_CR469","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.jacc.2013.03.003","volume":"61","author":"JC Tardif","year":"2013","unstructured":"Tardif, J. C. et al. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. J. Am. Coll. Cardiol. 61, 2048\u20132055 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2198_CR470","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1055\/s-0039-1677744","volume":"119","author":"V Denzinger","year":"2019","unstructured":"Denzinger, V. et al. Optimizing platelet GPVI inhibition versus haemostatic impairment by the Btk inhibitors ibrutinib, acalabrutinib, ONO\/GS-4059, BGB-3111 and evobrutinib. Thromb. Haemost. 119, 397\u2013406 (2019).","journal-title":"Thromb. Haemost."},{"key":"2198_CR471","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/jth.13604","volume":"15","author":"T Shirai","year":"2017","unstructured":"Shirai, T. et al. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice. J. Thromb. Haemost. 15, 513\u2013525 (2017).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR472","doi-asserted-by":"publisher","first-page":"42733","DOI":"10.18632\/oncotarget.5811","volume":"6","author":"YW Chang","year":"2015","unstructured":"Chang, Y. W. et al. Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis. Oncotarget 6, 42733\u201342748 (2015).","journal-title":"Oncotarget"},{"key":"2198_CR473","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121162","volume":"609","author":"HH Wu","year":"2021","unstructured":"Wu, H. H. et al. An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases. Int. J. Pharm. 609, 121162 (2021).","journal-title":"Int. J. Pharm."},{"key":"2198_CR474","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s10020-022-00556-8","volume":"28","author":"B Cheng","year":"2022","unstructured":"Cheng, B. et al. Inhibition of platelet activation suppresses reactive enteric glia and mitigates intestinal barrier dysfunction during sepsis. Mol. Med. 28, 127 (2022).","journal-title":"Mol. Med."},{"key":"2198_CR475","doi-asserted-by":"crossref","unstructured":"Dandamudi, A., Akbar, H., Cancelas, J. & Zheng, Y. Rho GTPase signaling in platelet regulation and implication for antiplatelet therapies. Int. J. Mol. Sci. 24, 2519 (2023).","DOI":"10.3390\/ijms24032519"},{"key":"2198_CR476","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.chembiol.2012.05.009","volume":"19","author":"X Shang","year":"2012","unstructured":"Shang, X. et al. Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases. Chem. Biol. 19, 699\u2013710 (2012).","journal-title":"Chem. Biol."},{"key":"2198_CR477","doi-asserted-by":"publisher","first-page":"e0163227","DOI":"10.1371\/journal.pone.0163227","volume":"11","author":"H Akbar","year":"2016","unstructured":"Akbar, H. et al. RhoA and Rac1 GTPases differentially regulate agonist-receptor mediated reactive oxygen species generation in platelets. PLoS ONE 11, e0163227 (2016).","journal-title":"PLoS ONE"},{"key":"2198_CR478","doi-asserted-by":"publisher","first-page":"C57","DOI":"10.1152\/ajpcell.2000.278.1.C57","volume":"278","author":"H Nagumo","year":"2000","unstructured":"Nagumo, H. et al. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am. J. Physiol. Cell Physiol. 278, C57\u2013C65 (2000).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2198_CR479","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-128","volume":"8","author":"S Dwivedi","year":"2010","unstructured":"Dwivedi, S. et al. Rac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque. J. Transl. Med. 8, 128 (2010).","journal-title":"J. Transl. Med."},{"key":"2198_CR480","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92654-6","volume":"11","author":"X Duan","year":"2021","unstructured":"Duan, X. et al. Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis. Sci. Rep. 11, 13170 (2021).","journal-title":"Sci. Rep."},{"key":"2198_CR481","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s11373-005-9021-2","volume":"12","author":"JC Chang","year":"2005","unstructured":"Chang, J. C., Chang, H. H., Lin, C. T. & Lo, S. J. The integrin alpha6beta1 modulation of PI3K and Cdc42 activities induces dynamic filopodium formation in human platelets. J. Biomed. Sci. 12, 881\u2013898 (2005).","journal-title":"J. Biomed. Sci."},{"key":"2198_CR482","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1182\/blood-2006-03-006338","volume":"108","author":"JM Cosemans","year":"2006","unstructured":"Cosemans, J. M. et al. Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood 108, 3045\u20133052 (2006).","journal-title":"Blood"},{"key":"2198_CR483","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ejmech.2016.06.010","volume":"122","author":"Z Zheng","year":"2016","unstructured":"Zheng, Z. et al. Discovery and antiplatelet activity of a selective PI3K\u03b2 inhibitor (MIPS-9922). Eur. J. Med. Chem. 122, 339\u2013351 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"2198_CR484","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/jth.13027","volume":"13","author":"S Nylander","year":"2015","unstructured":"Nylander, S. et al. Exploration of efficacy and bleeding with combined phosphoinositide 3-kinase \u03b2 inhibition and aspirin in man. J. Thromb. Haemost. 13, 1494\u20131502 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR485","doi-asserted-by":"publisher","first-page":"107630","DOI":"10.1016\/j.pharmthera.2020.107630","volume":"217","author":"O Borst","year":"2021","unstructured":"Borst, O. & Gawaz, M. Glycoprotein VI\u2014novel target in antiplatelet medication. Pharm. Ther. 217, 107630 (2021).","journal-title":"Pharm. Ther."},{"key":"2198_CR486","doi-asserted-by":"crossref","unstructured":"Harbi, M. H. et al. Antithrombotic effects of fostamatinib in combination with conventional antiplatelet drugs. Int. J. Mol. Sci. 23, 6982 (2022).","DOI":"10.3390\/ijms23136982"},{"key":"2198_CR487","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2017-09-808808","volume":"131","author":"K Busygina","year":"2018","unstructured":"Busygina, K. et al. Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans. Blood 131, 2605\u20132616 (2018).","journal-title":"Blood"},{"key":"2198_CR488","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1160\/TH13-01-0014","volume":"110","author":"J Yeung","year":"2013","unstructured":"Yeung, J. et al. 12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity. Thromb. Haemost. 110, 569\u2013581 (2013).","journal-title":"Thromb. Haemost."},{"key":"2198_CR489","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1161\/ATVBAHA.117.309868","volume":"37","author":"R Adili","year":"2017","unstructured":"Adili, R. et al. First selective 12-LOX inhibitor, ML355, impairs thrombus formation and vessel occlusion in vivo with minimal effects on hemostasis. Arterioscler. Thromb. Vasc. Biol. 37, 1828\u20131839 (2017).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR490","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.febslet.2012.05.060","volume":"586","author":"BM Steele","year":"2012","unstructured":"Steele, B. M. et al. WNT-3a modulates platelet function by regulating small GTPase activity. FEBS Lett. 586, 2267\u20132272 (2012).","journal-title":"FEBS Lett."},{"key":"2198_CR491","doi-asserted-by":"crossref","unstructured":"Chaurasia, S. N. et al. Notch signaling functions in noncanonical juxtacrine manner in platelets to amplify thrombogenicity. eLife 11, e79590 (2022).","DOI":"10.7554\/eLife.79590"},{"key":"2198_CR492","doi-asserted-by":"publisher","first-page":"5024","DOI":"10.1182\/bloodadvances.2021006560","volume":"6","author":"A Tiwari","year":"2022","unstructured":"Tiwari, A. et al. Noncanonical Sonic Hedgehog signaling amplifies platelet reactivity and thrombogenicity. Blood Adv. 6, 5024\u20135040 (2022).","journal-title":"Blood Adv."},{"key":"2198_CR493","doi-asserted-by":"publisher","first-page":"19836","DOI":"10.1073\/pnas.0906268106","volume":"106","author":"BM Steele","year":"2009","unstructured":"Steele, B. M. et al. Canonical Wnt signaling negatively regulates platelet function. Proc. Natl Acad. Sci. USA 106, 19836\u201319841 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2198_CR494","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1182\/blood.V95.7.2289","volume":"95","author":"G Khetawat","year":"2000","unstructured":"Khetawat, G. et al. Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression. Blood 95, 2289\u20132296 (2000).","journal-title":"Blood"},{"key":"2198_CR495","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2012-01-405498","volume":"120","author":"MC Val\u00e9ra","year":"2012","unstructured":"Val\u00e9ra, M. C. et al. Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor \u03b1. Blood 120, 1703\u20131712 (2012).","journal-title":"Blood"},{"key":"2198_CR496","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1182\/blood-2005-04-1723","volume":"106","author":"LA Moraes","year":"2005","unstructured":"Moraes, L. A. et al. Ligand-specific glucocorticoid receptor activation in human platelets. Blood 106, 4167\u20134175 (2005).","journal-title":"Blood"},{"key":"2198_CR497","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/cvr\/cvy044","volume":"114","author":"AJ Unsworth","year":"2018","unstructured":"Unsworth, A. J., Flora, G. D. & Gibbins, J. M. Non-genomic effects of nuclear receptors: insights from the anucleate platelet. Cardiovasc. Res. 114, 645\u2013655 (2018).","journal-title":"Cardiovasc. Res."},{"key":"2198_CR498","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1152\/physrev.00003.2003","volume":"83","author":"RM Losel","year":"2003","unstructured":"Losel, R. M. et al. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83, 965\u20131016 (2003).","journal-title":"Physiol. Rev."},{"key":"2198_CR499","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-018-0669-2","volume":"11","author":"M Schlesinger","year":"2018","unstructured":"Schlesinger, M. Role of platelets and platelet receptors in cancer metastasis. J. Hematol. Oncol. 11, 125 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"2198_CR500","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.bcp.2012.02.006","volume":"83","author":"E Liverani","year":"2012","unstructured":"Liverani, E. et al. Prednisolone exerts exquisite inhibitory properties on platelet functions. Biochem. Pharm. 83, 1364\u20131373 (2012).","journal-title":"Biochem. Pharm."},{"key":"2198_CR501","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/jth.13578","volume":"15","author":"AJ Unsworth","year":"2017","unstructured":"Unsworth, A. J. et al. PPAR\u03b3 agonists negatively regulate \u03b1IIb\u03b23 integrin outside-in signaling and platelet function through up-regulation of protein kinase A activity. J. Thromb. Haemost. 15, 356\u2013369 (2017).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR502","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1161\/ATVBAHA.116.308093","volume":"36","author":"LA Moraes","year":"2016","unstructured":"Moraes, L. A. et al. Farnesoid X receptor and its ligands inhibit the function of platelets. Arterioscler. Thromb. Vasc. Biol. 36, 2324\u20132333 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2198_CR503","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1111\/jth.13861","volume":"15","author":"H Schwertz","year":"2017","unstructured":"Schwertz, H. et al. Retinoic acid receptor-\u03b1 regulates synthetic events in human platelets. J. Thromb. Haemost. 15, 2408\u20132418 (2017).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR504","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.freeradbiomed.2019.01.007","volume":"136","author":"E Fuentes","year":"2019","unstructured":"Fuentes, E., Araya-Maturana, R. & Urra, F. A. Regulation of mitochondrial function as a promising target in platelet activation-related diseases. Free Radic. Biol. Med. 136, 172\u2013182 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"2198_CR505","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1182\/bloodadvances.2018022392","volume":"2","author":"MK Nayak","year":"2018","unstructured":"Nayak, M. K. et al. Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis. Blood Adv. 2, 2029\u20132038 (2018).","journal-title":"Blood Adv."},{"key":"2198_CR506","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1182\/blood.2020007140","volume":"137","author":"MK Nayak","year":"2021","unstructured":"Nayak, M. K. et al. The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis. Blood 137, 1658\u20131668 (2021).","journal-title":"Blood"},{"key":"2198_CR507","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000500492","volume":"47","author":"D Liu","year":"2020","unstructured":"Liu, D. et al. Effects and mechanisms of vitamin C post-conditioning on platelet activation after hypoxia\/reoxygenation. Transfus. Med. Hemother. 47, 110\u2013118 (2020).","journal-title":"Transfus. Med. Hemother."},{"key":"2198_CR508","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112187","volume":"192","author":"D M\u00e9ndez","year":"2020","unstructured":"M\u00e9ndez, D. et al. Synthesis of antiplatelet ortho-carbonyl hydroquinones with differential action on platelet aggregation stimulated by collagen or TRAP-6. Eur. J. Med. Chem. 192, 112187 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"2198_CR509","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114341","volume":"183","author":"D M\u00e9ndez","year":"2021","unstructured":"M\u00e9ndez, D. et al. Synthesis and pharmacological evaluation of acylhydroquinone derivatives as potent antiplatelet agents. Biochem. Pharm. 183, 114341 (2021).","journal-title":"Biochem. Pharm."},{"key":"2198_CR510","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1182\/bloodadvances.2019000182","volume":"4","author":"N Abbasian","year":"2020","unstructured":"Abbasian, N. et al. Supramaximal calcium signaling triggers procoagulant platelet formation. Blood Adv. 4, 154\u2013164 (2020).","journal-title":"Blood Adv."},{"key":"2198_CR511","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1073\/pnas.1717956115","volume":"115","author":"R Watanabe","year":"2018","unstructured":"Watanabe, R., Sakuragi, T., Noji, H. & Nagata, S. Single-molecule analysis of phospholipid scrambling by TMEM16F. Proc. Natl Acad. Sci. USA 115, 3066\u20133071 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2198_CR512","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/ijlh.13998","volume":"45","author":"J Jin","year":"2023","unstructured":"Jin, J. et al. High-purity isolation platelets by gradient centrifugation plus filtration. Int. J. Lab. Hematol. 45, 187\u2013194 (2023).","journal-title":"Int. J. Lab. Hematol."},{"key":"2198_CR513","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/09537104.2016.1209478","volume":"28","author":"A Wrzyszcz","year":"2017","unstructured":"Wrzyszcz, A., Urbaniak, J., Sapa, A. & Wo\u017aniak, M. An efficient method for isolation of representative and contamination-free population of blood platelets for proteomic studies. Platelets 28, 43\u201353 (2017).","journal-title":"Platelets"},{"key":"2198_CR514","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1182\/blood-2012-04-416594","volume":"120","author":"JM Burkhart","year":"2012","unstructured":"Burkhart, J. M. et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 120, e73\u2013e82 (2012).","journal-title":"Blood"},{"key":"2198_CR515","doi-asserted-by":"crossref","unstructured":"Chaudhary, P. K., Upadhayaya, S., Kim, S. & Kim, S. The perspectives of platelet proteomics in health and disease. Biomedicines 12, 585 (2024).","DOI":"10.3390\/biomedicines12030585"},{"key":"2198_CR516","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1016\/j.cell.2024.04.018","volume":"187","author":"DM Poscablo","year":"2024","unstructured":"Poscablo, D. M. et al. An age-progressive platelet differentiation path from hematopoietic stem cells causes exacerbated thrombosis. Cell 187, 3090\u20133107.e3021 (2024).","journal-title":"Cell"},{"key":"2198_CR517","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.thromres.2023.12.008","volume":"234","author":"AK Rohlfing","year":"2024","unstructured":"Rohlfing, A. K. et al. cGMP modulates hemin-mediated platelet death. Thromb. Res. 234, 63\u201374 (2024).","journal-title":"Thromb. Res."},{"key":"2198_CR518","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.immuni.2023.05.007","volume":"56","author":"H Wang","year":"2023","unstructured":"Wang, H. et al. Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection. Immunity 56, 1410\u20131428.e1418 (2023).","journal-title":"Immunity"},{"key":"2198_CR519","doi-asserted-by":"crossref","unstructured":"D\u2019Ambrosi, S. et al. Combinatorial blood platelets-derived circRNA and mRNA signature for early-stage lung cancer detection. Int. J. Mol. Sci. 24, 4881 (2023).","DOI":"10.3390\/ijms24054881"},{"key":"2198_CR520","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2217\/fon-2023-0129","volume":"19","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. Tumor-educated platelet SNORA58, SNORA68 and SNORD93 as novel diagnostic biomarkers for esophageal cancer. Future Oncol. 19, 651\u2013661 (2023).","journal-title":"Future Oncol."},{"key":"2198_CR521","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jtha.2023.07.025","volume":"22","author":"S Kumar","year":"2024","unstructured":"Kumar, S., Schroeder, J. A. & Shi, Q. Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond. J. Thromb. Haemost. 22, 23\u201334 (2024).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR522","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1042\/ETLS20180153","volume":"3","author":"M Lawrence","year":"2019","unstructured":"Lawrence, M., Mueller, A. & Ghevaert, C. Using genome editing to engineer universal platelets. Emerg. Top. Life Sci. 3, 301\u2013311 (2019).","journal-title":"Emerg. Top. Life Sci."},{"key":"2198_CR523","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1096\/fj.05-5161fje","volume":"20","author":"T Ohmori","year":"2006","unstructured":"Ohmori, T. et al. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Ibalpha promoter: in vivo model for platelet-targeting gene therapy. FASEB J. 20, 1522\u20131524 (2006).","journal-title":"FASEB J."},{"key":"2198_CR524","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1538-7836.2007.02346.x","volume":"5","author":"Q Shi","year":"2007","unstructured":"Shi, Q. et al. Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A. J. Thromb. Haemost. 5, 352\u2013361 (2007).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR525","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/jth.14379","volume":"17","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. The impact of GPIb\u03b1 on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity. J. Thromb. Haemost. 17, 449\u2013459 (2019).","journal-title":"J. Thromb. Haemost."},{"key":"2198_CR526","doi-asserted-by":"publisher","first-page":"106722","DOI":"10.1016\/j.compbiomed.2023.106722","volume":"156","author":"ST Lien","year":"2023","unstructured":"Lien, S. T. et al. Establishment of extensive artificial intelligence models for kinase inhibitor prediction: identification of novel PDGFRB inhibitors. Comput. Biol. Med. 156, 106722 (2023).","journal-title":"Comput. Biol. Med."},{"key":"2198_CR527","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.thromres.2023.04.011","volume":"226","author":"Q Mo","year":"2023","unstructured":"Mo, Q. et al. Identification of thrombopoiesis inducer based on a hybrid deep neural network model. Thromb. Res. 226, 36\u201350 (2023).","journal-title":"Thromb. Res."},{"key":"2198_CR528","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fphys.2018.00491","volume":"9","author":"W Liu","year":"2018","unstructured":"Liu, W. et al. Application of feedback system control optimization technique in combined use of dual antiplatelet therapy and herbal medicines. Front. Physiol. 9, 491 (2018).","journal-title":"Front. Physiol."},{"key":"2198_CR529","doi-asserted-by":"crossref","unstructured":"Yeh, C. H. et al. Artificial-intelligence-assisted discovery of genetic factors for precision medicine of antiplatelet therapy in diabetic peripheral artery disease. Biomedicines 10, 116 (2022).","DOI":"10.3390\/biomedicines10010116"},{"key":"2198_CR530","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029900","volume":"13","author":"F Li","year":"2024","unstructured":"Li, F. et al. Dynamic prognosis prediction for patients on DAPT after drug-eluting stent implantation: model development and validation. J. Am. Heart Assoc. 13, e029900 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"2198_CR531","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1055\/s-0039-1693475","volume":"45","author":"D Mege","year":"2019","unstructured":"Mege, D. et al. Involvement of platelets in cancers. Semin. Thromb. Hemost. 45, 569\u2013575 (2019).","journal-title":"Semin. Thromb. Hemost."},{"key":"2198_CR532","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1080\/10717544.2021.1983071","volume":"28","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy. Drug Deliv. 28, 2051\u20132061 (2021).","journal-title":"Drug Deliv."},{"key":"2198_CR533","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fphar.2015.00252","volume":"6","author":"A Jeanne","year":"2015","unstructured":"Jeanne, A., Schneider, C., Martiny, L. & Dedieu, S. Original insights on thrombospondin-1-related antireceptor strategies in cancer. Front. Pharm. 6, 252 (2015).","journal-title":"Front. Pharm."},{"key":"2198_CR534","doi-asserted-by":"crossref","unstructured":"Napolitano, F. & Montuori, N. Role of plasminogen activation system in platelet pathophysiology: emerging concepts for translational applications. Int. J. Mol. Sci. 23, 6065 (2022).","DOI":"10.3390\/ijms23116065"},{"key":"2198_CR535","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1055\/s-0042-1758791","volume":"49","author":"GB Morrow","year":"2023","unstructured":"Morrow, G. B. & Mutch, N. J. Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1). Semin. Thromb. Hemost. 49, 305\u2013313 (2023).","journal-title":"Semin. Thromb. Hemost."},{"key":"2198_CR536","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/MBC.0000000000001271","volume":"35","author":"M Saboor","year":"2024","unstructured":"Saboor, M. et al. Exploring antithrombin: insights into its physiological features, clinical implications and analytical techniques. Blood Coagul. Fibrinolysis 35, 43\u201348 (2024).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"2198_CR537","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1026016628386","volume":"253","author":"N Gong","year":"2003","unstructured":"Gong, N. & Chatterjee, S. Platelet endothelial cell adhesion molecule in cell signaling and thrombosis. Mol. Cell Biochem. 253, 151\u2013158 (2003).","journal-title":"Mol. Cell Biochem."},{"key":"2198_CR538","doi-asserted-by":"crossref","unstructured":"Viglio, S., Iadarola, P., D\u2019Amato, M. & Stolk, J. Methods of purification and application procedures of alpha1 antitrypsin: a long-lasting history. Molecules 25, 4014 (2020).","DOI":"10.3390\/molecules25174014"},{"key":"2198_CR539","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02572-4","volume":"22","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases. Cancer Cell Int. 22, 156 (2022).","journal-title":"Cancer Cell Int."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02198-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02198-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02198-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:02:02Z","timestamp":1747335722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02198-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":539,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2198"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02198-8","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}